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"In a priapism the blood does not coagulate, 
except it threatens mortification. 11 
John Hunter, 1793. 
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- 2 -
INTRODUCTION 
The blood of man is rich in plasminogen, the inactive 
precursor of plasmin, a protease (Astrup, 1956a); the 
most characteristic action of plasmin is the digestion of 
fibrin, i.e. fibrinolysis. Many tissues, including the 
prostate (Rasmussen and Albrechtsen, 1960a), contain 
substances which can activate plasminogen, and thus 
initiate fibrinolysis, and it has been assumed that both 
the excessive fibrinolysis seen in the blood of some 
patients with prostatic disease (Tagnon, Whitmore, Schul-
man and Kravitz, 1953a), and in prostatic surgery 
(Lombardo, 1957), is due to the release of this activator 
into the blood stream (Fearnley, 1965). 
Human semen contains a substance which can activate 
the blood fibrinolytic system (von Kaulla and Shettles, 
1953). Indeed, when human seminal fluid is ejaculated, 
it undergoes a process resembling the clotting and 
fibrinolysis of the blood, by coagulating then liquefying 
spontaneously. The coagulum is formed when a fibrinogen-
like protein secreted by the seminal vesicles is acted 
upon by a clotting enzyme from the prostate (Mann, 1964). 
Coagulation is followed within about 20 minutes by 
liquefaction/ 
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liquefaction of the clots by an enzyme assumed to come from 
the prostate (Huggins and Neal, 1942). This enzyme 
resembles plasmin in that it is a protease acting on a 
fibrin-like substrate, and that it is derived from an 
inactive precursor. 
A great deal of knowledge has accumulated concerning 
the thrombosis of blood, and more recently, the blood 
fibrinolytic system. However, not only is the nature of 
the fibrinolytic system present in human semen obscure, 
but little is known of the source responsible for secreting 
such fibrinolytic substances into the seminal fluid. The 
exact role which such factors play in human reproduction 
has not been clearly decided, i.e. in the secretion and 
storage of seminal fluid; the cycle of coagulation and 
liquefaction of ejaculated semen; the interaction of such 
fibrinolytic substances with the secretions of the female 
genital tract during the ascent of motile spermatozoa; 
and in the fertilization of the human ovum. 
The question of the origin of plasminogen activator 
in seminal fluid then remains open. A semen-liquefying 
"fibrinolysin" has certainly been found in fluid obtained 
by prostatic massage (Huggins and Neal, 1942), but samples 
obtained/ 
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obtained by such a relatively crude method could not be 
purely of prostatic origin. Therefore, it seemed of 
interest to identify the tissue components in the male 
genital tract containing such activator. Using a hist-
ological technique - 11 fibrinolysis autography 11 , which 
demonstrates fibrinolysin activator, Todd (1958, 1959) 
has found the activator, in most tissues, to be concentrated 
in the blood vessels. In the prostate, the epithelium 
and secretions seemed inactive, contrary to what might be 
anticipated from the fibrinolytic activity of prostatic 
secretion. In his experiments, however, postmortem 
tissues were used, so that the possibility of decay of 
the activator before testing could not be excluded. 
To see whether prostatic epithelium contains any 
labile activator, twenty-five fresh, surgically removed 
prostate glands were examined (Kester, 1969), using the 
histo-chemical technique. The experiments confirmed the 
fibrinolytic activity of blood vessels, but also revealed 
that plasminogen activator is present in prostatic 
epithelium, but in amounts too small to be the entire 
source of the fibrinolytic activity in human semen fluid. 
Further studies were then carried out on samples of tissues 
taken/ 
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taken at necropsy from the organs of the male genital 
tract, i.e. testis, epidydimis, vas deferens, seminal 
vesicle, prostate, bulbo-urethral gland, corpus 
spongiosium and corpus cavernosum. Specimens of human 
semen and seminal vesicular fluid were likewise tested, 
and the effect of various factors on the sensitivity of 
plasminogen activator was studied. These experiments, 
and those on fresh prostatic tissue have been combined 
to form the basis of this thesis. Altogether, over 
2,000 histological preparations were examined. 
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PART I 
THE HISTORY OF FIBRINOLYSIS IN THE BLOOD 
Recorded knowledge of fibrinolysis commenced in the 
eighteenth century, when Morgagni (1769) was the first to 
observe that the blood remained fluid in cases of sudden 
death. He described the case of a man, who in 1725, was 
stabbed through the heart during a drunken brawl. He 
died shortly afterwards, and at the autopsy, Morgagni 
found the blood to be entirely fluid - 11 in general, more 
dissolv'd, and more wattery, than usual; perhaps .from 
the quantity of fluid that had been drunk." 
Morgagni's ovservation was closely followed by that 
of John Hunter (179.3), who noted that "in many modes of 
destroying life the blood is deprived of its power of 
coagulation, as happens in sudden death produced by many 
kinds of fits; by anger, electricity, or lightning; or 
by a blow on the stomach, etc. In these cases we find 
the blood, after death, not only in as fluid a state as 
in the living vessels but it does not even coagulate when 
taken out of them." He commented on the postmortem 
fluidity of the blood in two stags, chased until they 
dropped/ 
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dropped and died of exhaustion, and also on the rapid 
liquefaction of the blood in bats which had died after 
being disturbed in hibernation. 
When Arnold, Berzelius (all quoted by Arthus and 
Dastre, in 1893) and Denis demons~rated in 1838 that fibrin 
was soluble in the presence of salt solutions e.g. ammonium 
chloride, strong interest in this characteristic was 
aroused. Denis postulated that a blood clot could 
dissolve after some time. Zimmermann (1846) found that 
ox fibrin left immersed in a salt solution e.g. potassium 
nitrate, remained intact for up to 10 days, while fibrin 
obtained from human blood by wet cupping dissolved within 
12 - 24 hours. Limbourg showed in 1889 that fibrin was 
soluble in a wide range of salt solutions. Extensive 
experiments by Fermi (1891) revealed that many inorganic 
and organic acids dissolved fibrin. However he made no 
comment on the fact that when he left fibrin to stand in 
water, it dissolved. 
Green's findings, in 1887, weakened the prevailing 
theory that the dissolution of fibrin was just a simple 
process. He demonstrated that fibrin decomposed in 
solutions/ 
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solutions of neutral salts to form two different fibro-
globulins. The decomposition was not due to bacterial 
putrefaction, as the reaction proceeded at temperatures 
just above freezing point. Arthus (1893) confirmed that 
the disintegration of fibrin was not due to the presence 
of bacteria, by using sodium fluoride to sterilize the 
salt solution. 
Dastre, in 1893, was the first to introduce the term 
11 fibrinolysis 11 , after observing that clots, removed from 
dogs which had been exsanguinated, underwent spontaneous 
dissolution. He called this phenomenon "La f ibrinolyse". 
Furthermore, he demonstrated that the end-products of 
fibrinolysis were peptones and not globulins (1894a), but 
he rejected the idea that fibrinolysis was due to a protease, 
as the properties of the factor seemed dissimilar to that 
of trypsin or pepsin, and he did not believe that the 
factor was present in the blood (1894b). 
However, studies by Denys and Marbaix in l889 showed 
that dog serum incubated with solvents such as ether, 
alcohol or chloroform, developed the ability to digest 
casein or gelatin - "autodigestion du sang additionne de 
chloroforme. 11 / 
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chloroforme. 11 This reaction was inhibited by the addition 
of a trace of untreated dog serum. They concluded that 
the serum contained a 11 diges.tive ferment", and an inhibitor 
which is normally in excess, and which is destroyed by 
the solvents. Delezenne and Pozerski (1903) confirmed 
Dastre's work, and demonstrated too, that chloroform 
stimulates fibrinolysis. 
It was Nolf, who in 1904, observed that "la fibrinolyse" 
/ / / 
was due to a "substance secretee par la paroi vasculaire 11 , 
and he was the first to suggest that fibrinolytic activity 
arose from the walls of blood vessels. By means of 
numerous experiments, he demonstrated that injections of 
peptones into dogs increased the fibrinolytic activity of 
blood (1904); that the liver secreted a fibrinolytic 
inhibitor, since extirpation of the liver resulted in 
increased fibrinolysis (1905); and that leucocytes have 
a fibrinolytic function (1908a) 
Nolf postulated that the endothelial cells of blood 
vessels were covered by an ultra-microscopic layer of 
fibrin (1908b), originating the idea that fibrin formation 
occurs normally on certain cell surfaces in contact with 
the/ 
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the blood, and that this deposition is counterbalanced by 
fibrinolysis. He confirmed that when chloroform was mixed 
with mammalian and bird plasma, fibrinolysis was induced 
(1921). He experimented with the coagulant and fibrino-
lytic properties of snake venom (1922a), and he observed 
that defibrination occurred when chloroform-treated serum 
was injected intravenously into dogs (1922b). At the 
same time that Nolf began his studies, Hedin (1904) had 
discovered that the enzyme lysing fibrin was a globulin. 
That normal serum was capable of inhibiting proteolysis, 
had first been shown by Hildebrandt (1893) and next by 
Hahn (1897). Landsteiner (1900) revealed that the 
inhibitory factor did not reside in the serum globulin 
fraction, precipitated by half saturation with ammonium 
sulphate, but was present in the albumin portion 
precipitated by complete saturation with ammonium sulphate 
after removal of the globulin. This finding was supported 
by the observations of Opie and Barker (1907). Dale and 
Walpole (1916) examined the increased fibrinolysis in blood 
treated with chloroform, and showed that this was due to 
the destruction of an inhibitor, "anti-trypsin." 
After / 
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After Morawitz (1906) had suggested, when noting 
that the blood in cases of sudden death lacked fibrinogen, 
that this could be due to the digestion of fi~rin by an 
enzyme, Fidon, Gautier and Martin (1908) showed that dogs 
killed by drowning developed rapid lysis of their blood 
clots. A practical though macabre application of these 
observations was made by Yudin, who in 1936 reported 
that fluid cadaver blood from cases of sudden or violerit 
death had been used for transfusion services. Mole 
(1948) demonstrated that postmortem fibrinolysis was a 
normal phenomenon due to fibrinolysin arising from 
vascular endothelium; he thought that fibrinolytic 
activity was the natural physiological means whereby fibrin 
deposits are prevented from forming on the vascular 
endothelium in health. 
Tillett and Garner (1933) reported that filtrates of 
certain haemolytic streptococcal cultures exhibited marked 
fibrinolytic activity, due to an enzyme which they called 
"Fibrinolysin". Milstone (1941) elaborating further on 
this discovery, showed that digestion of purified fibrin 
was not possible, when using the streptococcal fibrino-
lysin; however, on addition of a small amount of normal 
serum/ 
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serum, fibrinolysis proceeded. Thus, a further substance 
was required for the reaction, which he called the 11 Lytic 11 
factor. Kaplan (1944) now found that Milstone's lytic 
factor was identical to the proteolytic globulin isolated 
from blood treated with chloroform (Tagnon, 1942). 
Christensen (1945), working with serum treated with 
streptococcal fibrinolysin, found that this substance 
activated an enzyme precursor in the serum, which he 
called profibrinolysin. This simple presentation of the 
action of the streptococcal factor was later proved not 
to be true. Christensen and MacLeod (1945) demonstrated 
that the fibrinolysis brought about by chloroform treatment 
and that due to addition of streptococcal extract were both 
due to the same enzyme. They changed the name strepto-
cocc al "f ibr inolysin" to II s treptokinase"; from its 
precursor 11 plasminogen", was derived the proteolytic 
enzyme 11 plasmin", and its inhibitor was named "antiplasmin". 
They showed that the rate of change of plasminogen to 
plasmin was proportionate to the _concentration of 
streptokinase. 
However, Macfarlane and Pilling (1946) considered that 
plasmin / 
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plasmin and antiplasmin were associated within the albumin 
fraction of the serum as a complex from which plasmin can 
be freed by the destruction of the inhibitor by chloroform; 
by dilution; or be dissociated by fractionation. Geiger 
(1952) questioned the validity of Christensen's scheme 
that streptokinase activated plasminogen to active plasmin, 
when differing results were obtained using plasminogen 
derived from the blood of various animals. He suggested 
that a complement-like factor was necessary. Indeed, 
further observations by Mullertz and Lassen (1953), and 
~ confirmed later by Sherry (1954), indicated that the 
scheme proposed by Christensen was not sufficient. 
Mullertz and Lassen found that although bovine plasminogen 
was not activated by streptokinase, it certainly became 
proteolytic if a small amount of human plasma globulin 
was added to the reaction. Thus, according to them, 
human blood contains both an inactive pro-enzyme plasmin-
ogen, and its inert pro-activator. Bovine plasma was 
deficient in pro-activator and therefore did not become 
proteolytic when treated with streptokinase. The 
reaction proceeds as follows (Astrup, 1956a): 
Pro-activator/ 
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Pro-activator+ Streptokinase - Activator 
Plasminogen + Activator 
Plasmin + Fibrin 
- Plasmin 
- Polypeptides 
This scheme is still accepted at present, but it may be 
possible that these fibrinolytic components may not be 
independent, but rather different forms of the plasminogen 
molecule (Kline, 1960). 
Fearnley (1953) demonstrated that labile blood 
activator was adsorbed to the surface of a fibrin clot, 
causing its lysis during incubation. A similar phenom-
enon of adsorption was observed by Sherry, Fletcher and 
Alkjaersig (1959), whereby activator was released when 
streptokinase entered a clot, and converted its intrinsic 
plasminogen to plasmin. Lysis of the clot then ensued. 
Kwaan and McFadzean (1956) demonstrated that by 
arresting the arterial supply to a limb, fibrinolytic 
activity arose from the ischaemic vessel walls, mainly 
from capillaries and smaller veins. In 1958, Kwaan, Lo 
and McFadzean reported that vascular endothelium releases 
activator. Todd (1958, 1959, 1964) showed that the 
intima of blood vessels was rich in activator, veins more 
so/ 
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so than arterieso Natural fibrinolysis in the blood can 
be demonstrated in normal persons, even at rest (Fearnley 
and Tweed, 1953), and it is apparent that far from being 
a passive system of collecting channels, the venous system 
has an active secretory function (Fearnley, 1965). 
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THE HISTORY OF TISSUE FIBRINOLYSIS 
The earliest experiments studying the lysis of fibrin 
by tissues were conducted by Halban and Frankl(1910). 
Tissue fragments were placed directly on a serum substrate 
in a Petri dish, and the degree of fibrinolytic activity 
was expressed by the area of digestion of the substrate. 
It was shown that endometrial tissue was capable of 
digesting serum substrates, and they assumed that this 
property was due to a trypsin-like enzyme. This method 
was relatively inaccurate and poorly standardized, and 
the results were based on inoividual judgement. Caffier 
(1930) made use of similar methods. 
Lambert and Hanes (1911) commented on the fibrinolysis 
of rat plasma media by tissue cultures of mouse sarcoma. 
Similarly, Carrell and Burrows (1911) were impressed by 
the finding that human breast cancer cells liquefied the 
plasma clots in which they were growing. Indeed, 
fibrlnolytic activity displayed by malignant tumour cells 
in vitro, proved to be an irksome hindrance to the 
cultivation of permanent strains of these cells, by early 
tissue culture workers. 
Whitehouse/ 
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Whitehouse (1914) showed that menstrual blood was 
actively fibrinolytic, and he suggested that the fluidity 
of the blood was due to the activity of a tissue enzyme. 
He found that clots made from blood taken from the arm were 
quickly lysed by fragments of endometrium. He demonstrated 
that this phenomenon happened during menstruation, by 
observing that blood taken directly from the uterine 
cavity first clotted, then reliquefied. He suggested 
that the tissues contained a specific enzyme which 
digested human fibrin, since it exhibited no effect on ox 
fibrin. 
Fleisher and Loeb (1915) investigated the fibrinolytic 
activity of a number of different tissues, by measuring 
the time taken for the lysis of a certain amount of clotted 
blood plasma, produced by tissue fragments in direct 
contact with the plasma. They placed the tissue fragments 
either on the clot, or the plasma was allowed to clot 
around the tissue, and they observed liquefaction of the 
clot around the tissue fragments after 24 hours. Even if 
the cells were first killed by chloroform, they were still 
able to digest the clot. They concluded that the tissues 
possessed a fibrinolytic enzyme. 
Demuth/ 
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Demuth and von Riesen (1928 ) studied the fibrinolytic 
activity of tissue cultures, and confirmed that the fibrin-
olytic activity of tissues was greatest at acid reaction. 
They suggested that the liquefaction of the plasma clot 
was due to dying cells liberating an "activator" of a 
proteolytic enzyme precursor present in the clot. There-
fore, they were the first to consider that an activator 
was required in the fibrinolytic mechanism. These find-
ings were confirmed several years later by Fischer (1946), 
while working with tissue culture media. He observed 
spontaneous lysis of chicken plasma clots by Rous chicken 
sarcoma cells; no lysis developed if the plas~a was heated 
0 
at 56 c. for 4 hours before incubation with the cells. 
He also concluded that the tumour cells released an 
activator which converted a precursor in the plasma to an 
active protease. 
The Development of the "Fibrin Plate" Me thod 
These pioneer studies on fibrin-digestion by tissues 
were expanded by Astrup and Permin (1947), who found that 
different tissues, especially those of fresh pork, contained 
an insoluble compound that activated profibrinolysin. 
They called this compound "fibrinokinase", a term later 
replaced/ 
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replaced by the more accept ab le "tissue activator of 
plasminogen". They demonstrated that the fluid expressed 
from fibrin clots became strongly fibrinolytic when 
incubated with tissue. Their attempt at aqueous extrac-
tion of this substance from tissues was unsuccessful, 
although suspensions of washed tissue fragments were very 
active. 
Astrup and Permin (1948), studying the fibrinolytic 
activity developed by an ox plasma fraction when mixed 
with various tissue extracts, found that when strepto-
kinase was used, no activation of the ox plasminogen 
occurred. Permin (1947) discovered that the proteolytic 
precursor activated by tissue extracts seemed to be 
identical with the plasmin formed when streptokinase 
activated plasminogen. The "fibrin plate method" was 
then developed by him to detect the presence of plasminogen 
activator in tissues. Here, a small amount of the tissue 
to be tested is placed on a thin layer of bovine fibrin, 
rich in plasminogen, covering the bottom of a Petri dish. 
After the preparation has been incubated at 37°c. for 20 
hours, fibrinolysis can be seen as a clear area of 
liquefaction/ 
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liquefaction around the tissue. 
Now, although certain tissues are able to digest 
untreated fibrin, this ability is lost on heating of the 
fibrin (Fleisher and Loeb, 1915). Therefore, if the 
bovine fibrin plate was heated at so0 c. for 30 minutes, 
the plasminogen was destroyed (Lassen, 1952). A further 
modification was to use human fibrin as a substrate. 
These three types of fibrin plate provided both a 
differentiation and a qualitative estimate of fibrinolytic 
activity. 
Tab le 1 ) : 
Lysis in the plates will occur when (see 
1. Plasmin digests fibrin in all three plates. 
2. The presence of plasminogen activator will lead 
to the digestion of only the human and the 
bovine unheated fibrin. 
3. Kinases e.g. streptokinase, will cause 
digestion only of human fibrin. 
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Table I 
T)·pe o f Plate Human Fibrin Bov i ne Fi bri n He a ted Bovi ne Fi bri n 
Fae to r s lh>-act .. i\a to r 
-
-
i nc Jude d Pl as min oge n PI as mi noge n -
i n Plate Fib r i n Fib r i n Fi br i n 
Strept oki nase + - -
Ac tiv ator + + -
Pl usmin + + + 
(from Mac far lane, 1964 ) 
By measuring the area of fibrinolysis produced by a given 
amount of the specimen in a given time, a quantitative 
estimate can be reached of the content of plasminogen 
activator in the specimen. 
~ The Properties of Tissue Activator 
Succeeding the development of the fibrin-plate 
method, the next decade was mainly concerned with 
elucidating the physical characteristics of the activator. 
Permin (1949) showed that tissue activator differed from 
cathepsins, in that the substance was not stimulated or 
inhibited/ 
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inhibited by a variety of papainase activators and 
inhibitors (glutathione, ascorbic acid, cysteine, hydro-
cyanic acid and potassium bromate). It had been shown 
previously too, by Goldhaber, Cornman and Ormsbee (1947) 
in studies with tissue cultures, that activator differed 
from cathepsins. When homogenised tissue preparations 
were centrifuged, fibrinolytic activity was associated 
with the microsome fraction (Tagnon and Petermann, (1949a), 
whereas the inhibitors of fibrinolysis were main 
concentrated in the supernatant fluid. 
Tissue activator is relatively heat-stable and is 
resistant to heating for 30 minutes at 37° - 50°c. over a 
broad pH range, and it is not destroyed even by heating to 
70°c. at acid reaction (Astrup and Sterndorff, 1956a). 
It can be stored for long periods in a frozen state without 
loss of activity (Tagnon and Petermann, 1949b; Lewis and 
Ferguson, 1950). This stability contrasts with that of 
the precursor of plasminogen activator found in normal 
blood (MHllertz and Lassen, 1953), which under the 
influence of so-called lysokinases, is converted into a 
plasminogen activator which is labile, especially at acid 
and/ 
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and alkaline reactions (Mullertz, 1955). Certain tissues 
have been studied, and have been found to contain such a 
lysokinase e.g. the kidney (Astrup and Sterndorff, 1956b). 
Extraction of the activator from tissues is possible 
with distilled water (Frankl and Aschner, 1911); with 
ammonium sulphate solutions (Astrup and Permin, 1948); 
saline (Rosenmann, 1920; Astrup and Sterndorff, 1952a); 
but it has been found that a 2-M potassium thiocyanate 
solution is a specific solvent (Astrup and Stage, 1952). 
A tissue-activator standard can be prepared as a dried 
powder, which will keep its stability for at least 18 
months when stored at -2o0 c. (Astrup, 1951). The 
presence of magnesium ions increases the solubility of the 
tissue activator (Bierstedt, 1955). 
Tissue activator can withstand the action of many 
chemicals, viz. acids, bases, toluol, alcohol, ether and 
chloroform (Fleisher and Loeb, 1915), acetone (Permin, 1947), 
but it is destroyed by formalin (Caffier, 1930). 
The Activation of Plasmi no en b Tissue Activ a tor. 
see Table 2: The Fibrinolytic Enzyme System 
Astrup (1951, 1952) has demonstrated that the amount 
of I 
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Activation 
Plasminogen 
--------------------> 
Ii' 
I 
I 
I 
I 
Spontaneous activation 
Chloroform 
Trypsin 
Tissue Activator 
Activator in urine 
Activator in blood, milk, etc. 
Plasmin 
Activation 
I 
I 
I 
I 
<:-------: 
Spontaneous activation 
Streptokinase 
I 
I 
Kinase in Blood 
1 Kinase 
L-
in tissue 
Pro-activator in blood, milk, etc. 
Table 2: The Fibrinolytic Enzyme System 
(after Astrup, 1956a) 
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of plasmin produced by this process varies with the 
concentration of both the tissue activator and plasminogen 
in such a manner, that increasing amounts of plasmin are 
formed on addition. either of increasing amounts of tissue 
activator to the same amounts of plasminogen, or of 
increasing amounts of plasminogen to the same amount of 
tissue activator. The reaction proceeds to equilibrium 
in a given time, so that complete conversion of the 
plasminogen in a given solution cannot be obtained even 
on addition of the strongest concentration of tissue 
activator. It has been further shown that the tissue 
activator inhibits the plasmin produced. It is thought 
that the tissue activator reversibly removes a blocking 
substance from plasminogen, so that this is converted 
into plasmin, and that the blocking substance should be 
attached to the activator, and that this complex should 
be able to inhibit the plasmin produced. 
Although these studies were confirmed by Permin (1949), 
and Lewis and Ferguson (1950), further experiments (Tagnon 
and Petermann, 1949b; Tagnon and Palade, 1950) refuted 
some of these observations. Increasing amounts of 
plasmin occurred only on addition of increasing amounts 
of tissue activator to a given amount of plasminogen 
whereas/ 
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whereas conversely, addition of increasing quantities of 
plasminogen to a given quantity of tissue activator did 
not increase the amount of plasmin produced. The process 
0 had its optimium reaction at pH 6.0-7.2. at 37 c. 
Localisation of the Source of Tissue Activator 
Rulot (1904), Barker (1908) and Nolf (1908a) all 
thought that leucocytes could cause fibrinolysis. There 
have been many speculations about the origin of fibrin-
olytic activity in blood (Nolf, 1904; Mole, 1948; Kwaan 
and McFadzean, 1956; Fearnley and Ferguson, 1958) who 
have all suggested that the active substance came from 
the lining of the blood vessels. Nolf (1908a) believed 
that the degree of fibrinolysis depended upon the amount 
of leucocyte and endothelial protoplasm entering into the 
formation of the clot. 
Mole (1948), after studying fibrinolysis in cadavers, 
suggested that the active globulin came from the endothe-
lium of blood vessels. Kwaan and McFadzean (1956) 
suggested that the capillaries and veinules were the 
source, after studying blood samples taken from ischaemic 
limbs. 
A micro-modification of Permints (1947) fibrin-
plate/ 
28 -
plate test was evolved by Todd, in 1958, called 1tfibrino-
lysis autography", where unfixed tissue sections were 
incubated on a film of plasminogen-rich bovine fibrin. 
From these studies, it was shown that the main. source of 
tissue activator was the endothelial cells of veins. 
Arterial endothelium and serosal cells contain pro-
activator (Todd, 1964); plasminogen activator was also 
found in the superficial endometrium at the time of 
menstruation; in squamous epithelium adjacent to areas 
of inflammation; and in thrombi and fibrinous pleural 
exudates. 
The histo-chemical technique has been used by Warren 
(1964), and has been made semi-quantitative by incubating 
a number of preparations of the tissues under study for 
varying periods between 10-60 minutes (Kwaan and Astrup, 
1964a, 1964b). The discovery, application and further 
developments of fibrinolysis autography is a major step 
forward in investigating the properties of a system of the 
body, whose potential significance is not fully understood. 
Activators in Other Body Fluids 
Macfarlane and Pilling reported in 1947 that human 
urine has fibrinolytic activity, and Ploug and Kjeldgaard 
(1957) later extracted urokinase in pure form. 
This/ 
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This physiological activator is being currently tested 
as a thrombolytic agent, as it is a non-antigenic, 
non-toxic activator of plasminogen. 
Plasminogen activators have been demonstrated in 
milk (Astrup and Sterndorff, 1953), tears (Storm, 1955), 
saliva (Albrechtsen and Thaysen, 1955), seminal fluid 
(von Kaulla, 1953), and ascitic fluid (Albrechtsen, 
Storm and Claassen, 1958). Pro-activators have been 
found in amniotic fluid (Albrechtsen and Trolle, 1955), 
in cerebro-spinal fluid; fluid from synovial cavities, 
hydroceles and blisters; lymph (Albrechtsen, Storm and 
Claassen, 1958). These substances are the precursors 
of an activator similar to the one formed in blood 
treated with streptokinase i.e. the activator is 
relatively labile, and is destroyed at acid reaction, 
and at temperatures of 7Q - 100°c. 
- .30 -
PART III 
THE HISTORY OF FIBRINOLYSIS RELATED TO REPRODUCTION 
In most animal species, semen is ejaculated in a 
liquid or a semi-liquid .state. In some species, e.g. 
the bull and the dog, the ejaculate remains fluid, but in 
others it is discharged either in a partly gelified state, 
or it becomes a gel or a firm coagulum soom afterwards 
(Mann, 1964). Human semen clots immediately after 
ejaculation, but it liquefies within about 20 minutes. 
Thoughtful observations were made as early as 1786 
by John Hunter, about the consistency of the secretions 
of the male genital apparatus. He did not agree with 
the current opinion that the glands called the "vesiculae 
seminales", situated between the rectum and the bladder, 
were "reservoirs for the semen, secreted by the testicles, 
in the same manner as the gall-bladder is supposed to be 
a reservoir for the bile", but were glands producing a 
characteristic mucous secretion "of a lightish whey 
colour, having nothing of the smell of semen; and in so 
fluid a state as to run out on cutting them11 • He 
observed that in rats the seminal vesicles contained 11 a 
thick/ 
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thick ash-coloured mucus, nearly of the consistence of 
soft cheese, very different from what is found in the 
vasa deferentia of the same animal, with which they do not 
communicate." A similar occurrence was found in the 
seminal vesicles of the guinea-pig, where the contents of 
the seminal vesicle were fluid near the fundus, but of 
cheese-like consistency near the ejaculatory ducts. 
In rodents, e.g. rats, mice and guinea-pigs, a 
vaginal plug or "bouchon vaginal" forms after mating, 
when emitted semen coagulates, and the coagulum serves 
to prevent the loss of seminal fluid from the vagina. 
The vaginal plug consists of protein material secreted 
by the seminal vesicles (Bischoff, 1852; Bergmann and 
Leuckart, 1852; Stockard and Papanicolaou, 1919). It 
was discovered by Camus and Gley (1896, 1922) that the 
coagulating factor was an enzyme, which they called 
"vesiculase". The source of this enzyme was pinpointed 
to the so-called coagulating gland, adjacent to the 
seminal vesicle (Walker, 1910). It was only during 
ejaculation that the enzyme came into contact with the 
protein substrate and coagulation then proceeded. 
If the normal mechanism of ejaculation is upset, 
clotting may occur within the male passages, e.g. semen 
may/ 
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may be ejaculated retrogradely into the urinary bladder 
of male rats to form a '.'soft calculus" here (Vulpe, 
Usher and Leblond, 1956); or cheese-like lumps may 
form in the urinary bladder of bilaterally adrena-
lectomized guinea-pigs, and these may frequently block 
the urethra (Clayton, Hammant and Hawkins, 1956). 
The coagulation of semen in rodents occurs in two 
stages (Mann, 1965): 
Procoagulase 
(seminal vesicles) 
Coagulinogen 
(seminal vesicles) 
+ Vesiculase 
(coagulating gland) 
+ Coagulase 
Coagulase 
(clotting enzyme) 
- Coagulated protein 
Investigating the properties of human semen, Huggins 
and Neal (1942) observed that the liquefaction of semen 
was due to a protease which they called 11 Fibrinolysin11 , 
because of its ability to digest fibrin clots obtained 
from the blood, and its resemblance to the fibrinolytic 
factor found in the filtrates of haemolytic streptococcal 
cultures (Tillett and Garner, 1933). They suggested 
that this enzyme was of prostatic origin. It was further 
observed that although dog prostatic fluid was rich in an 
enzyme digesting fibrinogen - 11 fibrinogenase 11 , the 
content of this protease in human seminal fluid was 
quite/ 
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quite low. 
Harvey (1949) extended these experiments performed 
by Huggins and his co-workers. She measured the time 
taken for blood clots to liquefy when a constant volume 
of oxalated blood was mixed with varying amounts of 
semen, and the blood was next clotted with calcium 
chloride. No connection was found between the level 
of fibrinolytic activity and the viscosity of the semen. 
Extremely viscous specimens of seminal fluid, however, 
did appear to have low fibrinolytic activity. 
During an analysis of human seminal fluid (van 
Kaulla, 1953; van Kaulla and Shettles, 1953), the 
samples were found to contain plasmin; plasmin 
inhibitors; "fibrino-lysokinase" (plasminogen activator) 
which activated "prolysin" or "profibrinolysin" (plas-
minogen); and a precursor activated by streptokinase. 
It was noted that the fibrinolytic activity of seminal 
fluid was enhanced by dilution (of the inhibitor). 
There was no relationship between the number of sperm-
atozoa and the fibrinolytic activity of the seminal 
fluid, because fibrinolysis occurred equally well in 
specimens of necro-, oligo-, and azo-spermia. Von 
Kaulla and Shettles concluded that human seminal fluid 
was the only body fluid to contain a free plasmin-like 
enzyme/ 
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enzyme un_der normal circumstances. 
Lundquist, Thorsteinsson and Buus (1955), in trying 
to isolate the various proteolytic components in seme n, 
discovered an amino-peptidase which hydrolysed dipeptides 
and tripeptides; a kinase; an arginine-esterhydrolysing 
enzyme, which digested benzoyl-1-arginine ethyl ester; 
and a proteinase resembling trypsin. The latter enzyme 
could digest casein, haemoglobin, and human and bovine 
fibrin. Huggins and his co-workers (1942, 1943), too, 
had demonstrated the similarity between the proteolytic 
properties of prostatic secretion and those of pancreatic 
trypsin. 
A further method of determining the fibrinolytic 
activity of seminal fluid was described by Ying, Day, 
Whitmore and Tagnon (1956), who measured the liberation 
of soluble radio-iodine from a substrate consisting of 
fibrin tagged with r 131 isotope. Using the fibrin-plate 
method, Rasmussen and Albrechtsen (1960b) confirmed von 
Kaulla's discoveries, by demonstrating in seminal plasma 
the presence of small amounts of plasmin, which could 
digest heated bovine fibrin; plasminogen activator; 
trypsin inhibitors; and small amounts of pro-activator 
(converted/ 
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(converted by streptokinase). The plasminogen activator 
was of the stable tissue type, similar to the thermostable 
activator found in homogenized prostatic tissue. 
In 1952, Lundquist isolated a "seminal fibrin" from 
human semen, which was readily digested by seminal and 
prostatic proteolytic enzymes to yield the same free amino 
acids found normally in liquefied semen. 
The mechanism of coagulation-liquefaction in human 
semen was summarised as follows (Mann, 1964): 
• 
1. Formation of a fibrin-like clot by the action of 
a clotting enzyme produced in the prostate, on a fibrinogen-like protein substance secreted by the 
seminal vesicleso 
2. Fibrinolysis occurred next, as the result of the 
action of a plasmin-like enzyme of prostatic 
origin, formed from an inactive precursor, due 
to the presence of plasminogen activator • 
.3. Further proteolysis of the lysed fibrin to form free amino-acids and ammonia. 
In 1954, von Kaulla and Shettles suggested that the 
fibrinolytic activity of semen may influence the power of 
spermatozoa to penetrate the zona pellucida of the ovum. 
The mechanism whereby a spermatozoon enters into the ovum 
has been studied mainly in invertebrates, rather than in 
mammals. Consideration has been paid to the part 
played/ 
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played by so-called lytic agents in the process of ovum 
fertilisation, and by the influence of what was previously 
called the "ovulase" activity of spermatozoa. 
Tyler (19.39) was the first to show that the lytic 
--agents were enzymic in nature, when he identified an "egg-
membrane lysin", a protease, in the sperm of the key-hole 
limpet and the abalone. Similar proteolytic substances 
were detected in sea-urchin spermatozoa by Tyler and 
O'Melveny (1941) which they called the "jelly-coat 
dissolving or precipitating protein-factor"; and an "egg-
surf ace liquefying agent" or "sperm lysin" (Runnstrom, 
Lindvall and Tiselius, 1944) was found in sea-urchin and 
salmon spermatozoa. 
It was noted that in invertebrates (Jean Dan, 1952, 
1956), contact of a special nature was established between 
the acrosome of the spermatozoon's head and the egg, 
before the rest of the spermatozoon could pass across the 
jelly-coat. This phenomenon was called the "acrosome 
reaction". Further observations by Colwin and Colwin 
(1960, 1961) supported the presence of this reaction, 
when studying the fertilisation process in the annelid 
Hydroides hexagonus. During fertilisation, the -sperm-
atozoon/ 
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spermatozoon bores a hole through the vitelline membrane 
of the egg by means of a lytic enzyme called the 
"vi telline-membrane lysin". 
Austin (1959) added to the speculation concerning 
the fertilisation process by suggesting that the 
perforatorium, a structure normally located between the 
acrosome and the sperm-nucleus, may possess a lytic 
enzyme which he provisionally named "zona lysin". The 
digestive action of this enzyme would lead to the 
penetration of the zona pellucida by the spermatozoon. 
It may be likely that the "zona lysin" could be a plasmin-
like enzyme formed during capacitation i.e., the process 
undergone by spermatozoa in the female genital tract 
prior to fertilisation of the ovum. 
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CHAPTER III 
THE SIGNIFICANCE OF FIBRINOLYSIS 
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THE SIGNIFICANCE OF FIBRINOLYSIS 
It was Nolf (1904) who first introduced the concept 
that fibrin deposition and removal are in a state of 
dynamic equilibrium, and that fibrinolysis was the natural 
sequence of blood coagulation. The idea that blood 
coagulation was a continuous physiological phenomenon 
within the vascular system (Allen, 1951; Jensen, 1956; 
Copley, 1957; Roos, 1957) was supported by Astrup (1955a, 
1956b), who postulated that the process of fibrin formation 
was continuous. The fibrinolytic reaction was co-existent 
with coagulation, and so removed excess fibrin deposits 
or blood clots. 
Circumstantial evidence favours the concept that 
continuous fibrin formation is balanced by fibrinolysis. 
Copley (1954), Roos (1957) and Woolf (1961) have attempted 
to prove that a thin layer of fibrin forms the lining of 
blood vessels. Salmon (1961) and Das, Allan, Woodfield 
and Cash (1967) have detected the presence of fibrin 
degradation products in normal blood, indicating that 
fibrinolysis may be a continuous phenomenon. 
Todd/ 
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Todd (1969b) believes that blood fibrinolytic activity 
may be a spill-over by-product, influenced by dilution in 
the blood stream, of a process occurring locally. He 
suggests that the fibrin film does not occur in close 
juxtaposition to the endothelial surface, but that it 
exists as a gel, forming a boundary zone between fibrinogen-
rich plasma in the plasmatic zone of flowing blood, and a 
zone of plasminogen activator which is in immediate contact 
with the endothelial cells. The fibrin layer may become 
wider due to the increase of thromboplastic substances, 
or due to a decrease in fibrinolytic activity, and this 
may lead to thrombosis. Alternatively, if the secretion 
of activator increases, then the fibrin gel layer will 
diminish, allowing the escape of fibrinogen-rich plasma 
into the vessel wall, and leading to the fibrinous 
vasculosis described by Lendrum (1961, 1964). 
There have been a number of reports where thrombosis 
has accompanied a decrease in fibrinolysis below that 
normally found in blood. 
Nilsson, Krook, Sternby, Soderberg and Soderstrom 
( 1961) / 
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(1961) described the presence of recurrent thrombosis in 
a patient with a normal plasminogen level, but with 
increased inhibition of its activationo Similarly, 
Nilsson, Nil~hn, Cronberg and Norden (1966) reported 
increased inhibition of a normal content of plasminogen, 
in a patient who succumbed after developing fibrin 
deposits and thrombosis in many arteries and veins. 
Brakman, Mohler and Astrup (1966) found increased 
inhibition of tissue activator in several patients who 
developed thrombotic episodes. A more recent report, 
providing further evidence of an abnormal coagulation-
fibrinolysis equilibrium in favour of thrombosis, has 
described the appearance of peripheral symmetrical gangrene 
in African children, associated with an abnormally low 
level of plasminogen activator and increased amounts of 
fibrinolytic inhibitor (Turpie, Forbes and McNicol, 1967). 
The administration of a specific plasminogen inhibitor viz. 
epsilon aminocaproic acid has reduced the fibrinolytic 
activity of circulating blood, resulting in widespread 
intravascular thrombosis (Naeye, 1962; Sharp, 1964). 
In many/ 
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In many unrelated clinical syndromes, disseminated 
intravascular coagulation or defibrination occurs, due to 
the release into the circulation of large amounts of 
thromboplastin from damaged tissues (Vreeken, 1965; 
Hardisty and Ingram, 1965; McKay, 1965), e.g. transfusion 
reactions, obstetrical accidents, major surgery, and in 
neoplastic disease • Pathoiogically increased fibrinolysis 
occurs as a secondary phenomenon, leading to a serious 
haemorrhagic condition • Indeed, McKay demonstrated 
fibrin deposits in many pathological conditions. 
Hardaway (1966) similarly found that disseminated intra-
vascular coagulation, accompanied by secondary fibrino-
lysis, occurred in the seriously shocked patient. 
The degradation of fibrinogen and fibrin leads to the 
formation of split products which are polypeptides. 
fibrin degradation products have been shown to have an 
These 
anticoagulant behaviour by Niewiarowski and Kowalski (1957) 
who confirmed the finding -by Gratia (1921) that lysed 
fibrin prolonged coagulation in normal plasma. This is 
attributed to a disorder of fibrin polymerisation so that 
a clot is formed which is structurally defective (Fletcher, 
Alkjaersig and Sherry, 1962). (See Table 3 for Scheme of 
activation and inhibition of Fibrinolysis). , 
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PLASMINOGEN~~~~--,. PLASMIN~~~~~ FIBRINOLYSIS 
ACTIVATOR > ~~============~~PROTEASE 
INHIBITOR~s--======~~ ~ INHIBITORS 
Tissue 
activator in 
inhibition in 
blood ACTIVATORS 
a-globulins in blood 
-globulins in blood 
Mingin in urine 
Urokinase 
inhibition in 
blood 
Tissue activator Pulmin in ox lung 
Table ,3: 
Urine activator 
Blood activator 
Staphy lokinase 
Pro-activator & 
streptokinase 
Pro-activator & 
lysokinase 
Kuni tz pancreas 
inhibitor 
Kallikrein inhibitor 
in parotid 
Epsilon amino caproic 
acid 
Inhibitors in legumes 
(soya bean, peanuts) 
A Scheme of Activation and Inhibition of the 
Fibrinolytic System • 
(from Brakman, 1967). 
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Fibrinolysis and Wound Healing 
Minor injuries to tissues continually occur, and the 
damaged tissues release thromboplastins, leading to 
fibrin formation. This extravascular coagulation is 
part of normal tissue repair processes (Astrup, 1956b, 
1958); the fibrinolytic system is a very powerful factor 
in the restoration of normal conditions in traumatized 
tissue (Astrup, 1955b; Astrup and Sterndorff, 1956a; 
Albrechtsen, 1957). It is suggested that the most 
frequent cause of fibrinolytic activity in the blood is 
due to tissue injuries (Stefanini, 1952), due to the 
liberation of plasminogen activator from damaged tissues 
(Tagnon, 1953) 
Fleisher and Loeb (1915) and Rosenmann (1920) 
suggested that the fibrinolytic activity of the tissues 
might prevent the formation of connective tissue, by 
digesting fibrin and so destroying the growth substrate 
of connective tissue cells. Extravascular coagulation 
provides a scaffolding for phagocytes and fibroblasts, 
and is important in the formation of connective tissue. 
Proteases and cathepsins from phagocytes and disintegrat-
ing tissues were believed to remove excess fibrin. 
However,/ 
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However, Kwaan and Astrup (1964a, 1964b) have shown that 
it is the fibrinolytic mechanism which produces fibrin 
dissolution in the healing wound. Increased or 
diminished fibrinolysis will interfere with the proper 
function of fibrin deposits in tissue repair. For 
instance, in patients with congenital deficiency of fibrin 
stabilizing factor (Factor XIII), excessive scar tissue 
forms after trivial injuries (Duckert, Jung and Shmerling, 
1961). 
In addition to evidence revealing the intravascular 
presence of fibrin, interstitial fibrin formation has been 
demonstrated in the extravascular space by Lendrum (1961, 
1964). The presence of fibrinogen occurring outwith the 
blood vessels has bean shown by Mcfarlane, Todd and 
Cromwell (1964) and by Freeman (1964). 
Fibrinolysis and Inflammation 
Fibrinolysis is closely associated with inflammation, 
since fibrin is a factor common to both. Dissolution of 
the fibrinous exudate in lobar pneumonia has been 
attributed partly to fibrinolysis, since the lung is rich 
in activator. 
have/ 
Studies on leucocytes trapped in thrombi 
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have shown them to possess fibrinolytic activity (Todd 
and Nunn, 1967). Low fibrinolytic activity in patients 
with rheumatoid arthritis was corrected by corticosteroid 
therapy (Chakrabarti, Fearnley and Hocking, 1964). 
Fibrinolytic enzymes have accordingly been used topically 
to assist in "physiological debridement" (Cliffton, 1960) 
of fibrinous exudates. The idea that certain chronic 
diseases e.g. hyaline membrane disease, kwashiokor, cystic 
fibrosis of the pancreas and chronic relapsing pancreat-
itis, may be mediated by defective fibrinolysis, has been 
prompted by Innerfield (1960). 
Phillips and Skrodelis (1958) have detected 
diminished fibrinolytic activity in the blood of infants 
with hyaline membrane disease of the lungs. Further 
studies have revealed that there is a deficiency of tissue 
activator of plasminogen, due to the presence of an 
inhibitor in the lungs of such infants (Lieberman, 1961). 
Treatment of the disease has been attempted with plasmin 
because of the discovery of a reduced level of blood 
plasminogen (Ambrus, Weintraub, Dunphy, Dowd, Pickren, 
Niswander, and Ambrus, 1963). 
Fibrinolysis/ 
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Fibrinolysis and Vascul a r Dis e ase 
Labile activator is adsorbed to the surface of a 
fibrin clot from the circulating blood (Fearnley, 1953). 
In static blood, inhibition outweighs fibrinolytic 
activity (Fearnley, 1961), so that whilst in a mural or 
retracted thrombus, activator is available for adsorption 
and concentration from circulating blood, yet in occlusive 
thrombosis, the circulation ceases and activator is not 
available. 
The endothelium adjacent to thrombi in veins, 
pulmonary arteries, cardiac atria and coronary arteries 
contains activator (Todd and Nunn, 1967; Todd, 1969a). 
In cases where the thrombus has been loosened, activator 
can be detected upon the fibrin surface. Activator can 
also be detected within the thrombus, apparently trapped 
by retraction or re-thrombosis. These workers therefore 
express the suspicion that plasminogen activator plays a 
major part in the loosening of thrombus and the detachment 
of emboli. 
Although the endothelium of veins and pulmonary 
arteries are rich in activator, arteries on the other hand, 
are/ 
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are deficient in activator and contain pro-activator 
(Todd, 1959, 1964). The adventitia of arteries have been 
shown to be rich in activator, but the substance is absent 
from the intima and media (Astrup and Claassen, 1958). 
Naimi, Goldstein and Proger (1963) have shown that the 
fibrinolytic activity of arterial blood was significantly 
lower than that of venous blood. 
Reviving von Rokitanskyrs (1852) "encrustation theory" 
of atheroma formation, Duguid formulated in 1946 his 
thrombogenic theory of atherosclerosis. By carrying out 
comparative histological studies, he observed that fibrin 
deposits on the arterial intima became organized and 
changed into atherosclerotic plaques. There is evidence 
to indicate that low fibrinolytic activity occurs in 
occlusive vascular disease (Nestel, 1959; Fearnley, 1965); 
in diabetes mellitus (Fearnley, Chakrabarti and Avis, 
1963); and in myocardial ischaemia (Chakrabarti, Fearnley, 
Hocking, Delitheos and Clarke, 1966). 
Thrombolytic Th e rapy 
(see Table 4 for Pathophysiology of Thrombolysis) 
The presence of activator is necessary for the 
dissolution of thrombi. 
have/ 
Sherry and his co-workers (1959) 
PLASl\IINOGEN-PLASl\IIN SYSTEM 
IN THRO;\!BUS IN PLASMA 
Plasminogen 
I 
I 
I 
Activator ~ 
Plasmin 
Activator 
Clot Fibrin- - - - - -), Dissolution 
- - - -1 
Table Ii: 
Fibrinoge n 
Fibrin 
Accelerator Globulin 
Complement 
I 
I 
Other Plasma Proteins 1 
Pathophysiology of Thromboly sis 
(afte r A.P. Fletcher, 1960) 
Plasminogen 
f 
I 
I 
I 
..... 
Plasmin 
I 
I 
I 
V 
An tip lasmins ~ 
Products 
--) of 
Proteolysis 
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have demonstrated that activator diffuses into a thrombus 
and converts the intrinsic plasminogen of the thrombus to 
plasmin, thereby causing its lysis. Thrombolytic 
therapy has developed mainly along two paths. Firstly, 
over the short term, by the treatment of established 
venous or arterial thrombosis, or pulmonary embolism, 
with powerful exogenous activators of plasminogen e.g. 
streptokinase (Verstraete, Vermylen, Amery and Vermylen, 
1966; Bose, Brose and Hartley, 1969; Kakkar, Howe, 
O'Shea, Flute and Clarke, 1969) and urokinase (Mavor and 
Galloway, 1969; Prentice, McNicol and Douglas, 1969). 
Secondly, by the method of long-term activation for 
the prevention of intravascular fibrin deposition. 
Meaningful results have been achieved by the use of 
several pharmacological agents to enhance blood fibrino-
lytic activity viz.: 
Nicotinic acid 
Sulphonyl-ureas 
(Weiner, Redisch and 
Steele, 1958). 
(Fearnley, Chakrabarti 
and Vincent, 1960). 
Testosterone and Nandrolone 
(Fearnley and Chakrabarti, 1962). 
Phenformin and Clofibrate 
(Fearnley and Chakrabarti, 
1964). I 
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Prednisolone, Cortisone and ACTH 
(Chakrabarti, Fearnley and 
Hocking, 1964). 
The combination of phenformin and ethyloe5trenol 
would seem to be suitable as a prophylactic measure in 
arteriopathic patients, because of the sustained and 
favourable effect by increasing the fibrinolytic activity 
of the blood and reducing the plasma fibrinogen, the 
stickiness of platelets and the serum cholesterol. 
(Fearnley and Chakrabarti, 1969). 
PATHOLOGICAL FIBRINOLYSIS 
I Since Jurgens and Trautwein (1930) first described 
a haemorrhagic diathesis due to fibrinolysis, occurring 
in a patient with disseminated carcinoma of the prostate, 
over 100 similar cases have been described (see Table 5 
for list of cases recorded). Metastatic lesions, 
especially in the bones, seemed to be necessary for the 
development of pathological fibrinolysis, and extracts of 
both primary tumours, and of their metastases were rich 
in fibrinolytic activity (Tagnon and others, 1953a). 
In association with such fibrinolysis, deficiencies 
of I 
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TABLE 5 
Cases of Prostatic Cancer with Hyper-
fibrinolysis and a Haemorrhagic Diathesis 
Reference 
Aboulker, Soulier, Larrieu and Wartelle .(1955) 
Aggeler and Seale (1951) 
Andersson (1963a) 
Balfour (1959) 
Bergen and Schilling (1958) 
Boros, Tarnoky, Vereczkey and Rak (1962) 
Bredt (1962) 
Brown, Campbell and Thompson (1962) 
Burghele, Papadopol, Hozoc and Burchi (1961) 
Cibert, Favre-Gilly, Traeger and Durand (1952) 
Cosgriff and Leifer (1952) 
Cottier, Leupold and Scheitlin (1955) 
Crane, Ware and Hamilton (1955) 
Croizat, Revol, Favre-Gilly and 
Thouverez (1955) 
Dolaz, Dolehide and Friedman (1955) 
Dossogne (1959) 
Fiehrer, Bordas, Migault and Renard (1957) 
Foret, Bounameaux and Lecarte (1959) 
Frick/ 
Noo of 
Cases. 
2 
12 
6 
2 
2 
I 
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Reference 
Frick (1956) 
Galeone and Pelocchino (1956) 
Hadorn ( 1953) 
Hayashi, Yano, Sakurai, Murakami, Kadota 
and Kusakari (1962) 
(Japanese authors: quoted by Hayashi and 
others, 1962) , 1961 
Herbst (1942) 
Jurgens and Trautwein (1930) 
Kellock and Gallagher (1958) 
Ledent and De Geeter (1959) 
Lee (1962) 
Leng-Levy, David-Chausse, Julien and 
Riviere (1959) 
Lombardo (1958) 
Malcolm and 0 1Connor (1963) 
Manrique and Horder (1965) 
Marchal, Duhamel, Samama and Flandrin (1963) 
Marchal, Escalier, Duhamel, Le Roux, Nivet 
and Samama (1959) 
Marder, Weiner, Shulman and Shapiro (1949) 
Meuwissen and Zaman (1956) 
Miller, Meisel, Jackson and Collier (1959) 
Naeye / 
No. of 
Cases. 
1 
1 
1 
' 
1 
1 
2 
1 
2 
1 
2 
1 
3 
1 
1 
1 
2 
1 
1 
1 
r:::, 511- .... 
Reference 
Naeye (1962) 
Neft, Dugdale, Biggs and Raines (1961) 
Nour-Eldin and Draisey (1963) 
Ohler, Fischer, Enders and Kikillus (1966) 
Pellman, Ridlon and Phillips (1966) 
Phillips, Skrodelis and Furey (1959) 
Plauchu, Potton, Brizard and Rouchon (1955) 
Prout, Siegel, Cliffton a~d Whitmore (1956) 
Ramioul (1960) 
Rapaport and Chapman (1959) 
Rasmussen and Schwartz (1957) 
Salomon and Stefanini (1954) 
Scott (1956) 
Seale, Jampolis and Bargen 0951) 
Serre, Izarn and Simon (1963) 
· Si gs tad ( 1 9 6 1 ) 
Stefan, Chrob~k, Nerad and Groh (1959) 
Stefanini and Dameshek (1955) 
~Stefanini and Gendel (1953) 
Stocker and Maier (1964) 
Suros and Foz (1965) 
Swan/ 
10. of 
Cases 
4 
3 
2 
3 
2 
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Reference Noo of Cases 
Swan and Kerridge (1965) 2 
Swan, Wood and Daniel ( 1 957) 2 
Tagnon, Whitmore, Schulman and Kravitz (195.3a) 6 
Vlaardingerbroek ( 1960) 1 
Watson, Schultz and Wikoff ( 194 7) 1 
Zeh and Oft (1954) 1 
Total Noo of Cases extracted from the H)5 literature 
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of fibrinogen and blood clotting factors occurred, 
together with a prolonged prothrombin time. The develop-
ment of such a haemorrhagic state was not related to the 
level of the serum acid phosphatase. The presence of sex 
hormones influenced the fibrinolytic activity of the 
tumour, since the administration of oestrogens was 
followed by the disappearance of pathological fibrinolytic 
activity, and a rise in the plasma fibrinogen level, 
whereas the giving of testosterone produced a fall in the 
plasma fibrinogen level, accompanied by the reappearance 
of fibrinolysis (Tagnon, Schulman, Whitmore and Leone, 
1953b). 
An increased level of fibrinolytic activity in the 
blood stream occurring after different types of prostat-
ectomy, has been noted (Scott, Matthews, Butterworth and 
Frommeyer, 1954; Lombardo, 1957; Rasmussen and Ladehoff, 
1959; Urlus, 1962). Severe blood loss from the 
prostatic bed has been attributed to the digestion of 
haemostatic blood clot by local tissue activators released 
from damaged tissues (Andersson and Nilsson, 1961; 
Koller, 1963), and to the urokinase content of the urine 
(McNicol, Fletcher, Alkjaersig and Sherry, 1961a, 1961b). 
Such/ 
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Such postoperative blood loss was effectively reduced 
by the administration of antifibrinolytic agents, e.g. 
epsilon aminocaproic acid and Trasylol (McNicol and others 
1961a, 1961b; Andersson and Nilsson, 1961; Sack, Spaet, 
Gentile and Hudson, 1962; Furstenberg; 1962, Beck, 
Schmutzler and Duckert, 1963; Schmutzler and Furstenberg, 
1966). It has been shown that there is a rough correlation 
etween the extent of lysis of plasma clots by tissue 
cultures of hyperplastic prostates and the severity of 
postoperative haematuria (Kallen and Rohl, 1960). 
Significantly raised levels of fibrinolytic activity 
have been recorded in neoplastic disease (Dillard and 
Chanutin, 1949; Stefanini and Dameshek, 1955; Zucker, 
1964). A fatal bleeding state, due to a tremendous hyper-
plasminaemia in association with an operation on a case 
of carcinoma of the pancreas, was recorded by Ratnoff 
(1952 ). Other similar instances of a fatal bleeding 
condition have been noted in metastasizing cancer of the 
pancreas (McKay, Mansell and Hertig, 1953; Frick, 1956), 
and in cancer of the Ampulla of Yater (Crehan, 1957). 
Increased fibrinolytic activity in the blood associated 
with a bleeding diathesis has been seen in cases of 
disseminated/ 
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disseminated cancer of the bladder (Lombardo, 1958; 
Stefanini, 1958). 
A haemorrhagic syndrome accompanied by hypofibrino-
genaemia, is most commonly associated with an adenocarcinoma 
which has metastasized to the bone marrow, viz. stomach 
(Fleischhacker, 1940; Frick, 1956; Boomgaard and Moers, 
1963; Welborn, Brennan and Hathaway, 1 964); bronchus 
(Schmid, 1951; Cohen and Kupfer, 1958); gallbladder 
(Braun and Horanyi, 1951); uterus (Bennike and Mulleritz, 
1952). 
It is likely that many of these cases are examples 
of the syndrome of disseminated intravascular coagulation 
or defibrination (Hardisty and Ingram, 1965; McKay, 1965), 
following the release of thromboplastic substances from 
the tumour into the bloodstream. Clotting factors and 
platelets are seriously depleted by their consumption in 
this wide-spread clotting process, leading to a dangerous 
bleeding state. The situation is aggravated by secondary 
fibrinolysis, which as a defence mechanism, removes these 
fibrin deposits within the small vessels. 
It/ 
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It has b e en shown that the lung is rich in tissue 
activator (Albre chtsen, 1957), and that activator is 
concentrated more in the pulmonary arteries rather than 
in the pulmonary veins (Todd, 1959). The liberation of 
activator from the lung leads to a higher level of 
fibrinolytic activity in ·the blood in the pulmonary vein 
than in the pulmonary artery (Mathey, Daumet, Soulier, 
Le Bolloch and Fayet, 1950; Lincoln, Moorman and Schultz, 
1957). It is then not surprising that operations on the 
lung have incurred a haemorrhagic diathesis (Mathey and 
others, 1950; Chalnot, Michon and Lochard, 1952; Soulier, 
Mathey, Le Bolloch, Daumet and Fayet, 1952; Penn and 
Walker, 1954). 
Abnormal fibrinolysis has been reported in patients 
undergoing extracorporeal circulation during intra-cardiac 
surgery (von Kaulla and Swan, 1958; Andersen and Mendelow, 
1963; Tice, Reed, Clauss and Worth, 1963). Thyroid 
operations have similarly been accompanied by increased 
fibrinolysis (Lhoiry and Fayet, 1954). Obstetrical 
complications e.g. pre-eclamptic tozaemia, premature 
separation of the placenta, amniotic fluid embolism or 
infusion, incur the hazard of disseminated intravascular 
coagulation. / 
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· coagulation. 
A link between cirrhosis of the liver and excessive 
fibrinolysis leading to a bleeding state was first 
established by Goodpasture (1914). Nolf (1905) had 
earlier demonstrated that the fibrinolytic activity of 
blood increased when the liver was excluded from the 
circulation, and he surmised that this effect was due to 
the production of a fibrinolytic inhibitor by the liver. 
His assumptbn was supported by the finding that the blood 
in the hepatic veins was much lower in fibrinolytic 
activity than the blood in the systemic veins (Kwaan, 
McFadzean and Cook, 1957). 
Normal liver has been found to have a negligible 
activator content (Albrechtsen, 1957) whereas patients with 
cirrhosis have an increased fibrinolytic activity (Kwaan, 
and others, 1957). Todd (1961) has shown that the scar 
tissue of cirrhotic liver has a high content of activator. 
Indeed, there is a greatly reduced incidence of myocardial 
infarction in cases with cirrhosis (Howell and Manion, 
1960). Severe bleeding due to fibrinolysis may follow 
portocaval shunt operations (Marchal, Frileux, Bilsky-
Pasquier, / 
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Pasquier, Weiss, Cornet, Samama and Larrieu, 1959; Ende 
and Auditore, 1963). Bleeding from oesophageal varices 
has been influenced not only by the deficiency of clotting 
factors, but also by increased blood fibrinolysis when 
the damaged liver parenchyma fails to produce anti-
fibrinolysin (Tocantins, Reid, Silver and Kazal, 1964). 
Therapeutic Inhibitors of Pathological Fibrinolysis 
Even though it has been demonstrated that the amount 
of plasmin inhibitors in the plasma is thirty-fold the 
content of plasmin (Norman, 1958), a bleeding diathesis 
may still occur when excess plasmin appears in the blood 
stream. 
necessary. 
Treatment with fibrinolytic inhibitors is then 
Epsilon aminocaproic acid (EACA) has been most 
commonly used as a fibrinolytic inhibitor (Okamoto, 1954; 
Sato, Ishibashi, Endo, Watanabe and Nakajima, 1959) since 
its original use in animal experiments (Thomas and Goerne, 
1914). It inhibits plasmin at a concentration. of 5 X 
l0-2M or above, while at a concentration of 10-~, it 
inhibits the activation of plasminogen (Ablondi, Hagan, 
Philips and de Renzo, 1959; Alkjaersig, Fletcher and 
Sherry/ 
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Sherry, 1959). 
EACA has been used to reduce postprostatectomy bleeding 
by inhibiting urokinase activity in the urine (McNicol and 
others, 1961a, 1961b); in the treatment of haemorrhagic 
blood fibrinolysis in cases of prostatic disease (Andersson, 
1963b), and to reduce the postoperative blood loss after 
open-heart surgery (Sterns and Lillehei, 1967). In contrast, 
EACA has been administered to haemophiliacs, resulting in 
an appreciable decrease in the number of spontaneous bleed-
ing episodes (Mainwaring and Keidan, 1965; Gordon, McNicol, 
Dubber, McDonald and Douglas, 1965). It was postulated 
that the clinical improvement resulted from an alteration 
produced in the normal dynamic equilibrium between fibrin 
formation and fibrin digestion, in favour of a delay in 
fibrinolysis. 
The substance Trasylol (Aprotinin), derived from 
bovine parotid also inhibits activation of plasminogen (Marx, 
Clemente, Werle and Appel, 1959; Steichele and Herschlein, 
1961), and when combined with EACA, the blood loss after 
prostatectomy was effectively reduced by over five-fold 
(Schmutzler and Furstenberg, 1966). A further compound, 
"AMCHA" (Trans-aminomethy lcyc lohexane c arboxy lie acid), has 
proved to be even more potent as a fibrinolytic inhibitor 
than EACA (Okamoto and Okamoto, 1962; Maki and Beller, 
1966). , 
CHAPTER IV 
MATERIALS AND METHODS 
- 64 -
MATERIALS AND METHODS 
MATERIALS 
Human tissues: Blocks of tissue were taken from prostate 
glands immediately after enucleation prostatectomy; 
specimens of testis, epidydimis, vas deferens, seminal 
vesicle, seminal vesicular fluid, prostate, bulbo-urethral 
gland, corpus spongiosium and corpus cavernosum were 
obtained at routine postmortem examinations performed on 
14 adult males within 12 - ?4 hours after death. Tissues 
were only obtained from those males below the age of 65 
years, where possible. Further details concerning the 
sources of postmortem tissues are given in Table 6. 
Samples of human seminal fluid were obtained from the 
Infertility Clinic for Men, Dundee Royal Infirmary. 
Preservation media: Tissue culture medium No. 11 199 11 
(Morgan, Morton and Parker, 1950) (Glaxo Labs., Ltd.). 
Michaelis Veronal buffer-salirie (Biggs and Macfarlane, 
1963), pH 7.4, ionic strength 0.16, with sodium azide 
0.1% as a bacteriostatic. The buffer-saline was made 
by dissolving the reagents listed below in distilled 
water, and making up the total volume to 2.5 litres: 
Sodium/ 
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TABLE 6: Details of Source of Human Tissues 
Case 
Noo 
1 
2 
.3 
* 4 
5 
6 
7 
8 
9 
10 
1 1 
12 
13 
14 
15 
Age Postmortem Cause of Death No . 
68 6307 Chronic Lymphatic Leukaemia 
55 6330 Cancer of Caecum 
46 6358 Cerebral Haemorrhage 
'~3 105064 Orchidectomy 
58 6771 Cancer of Colon 
82 6770 Cardiac Failure 
77 6774 Cancer of Pancreas 
44 6773 Muscular Dystrophy 
60 E337/68 Cerebral Infarction 
22 Forensic Multiple Injuries 
44 E.344/68 Myocardial Infarction 
63 6793 Cancer of Stomach 
58 6907 Cardiac Failure 
57 E76/69 Myocardial Infarction 
61 6918 Cancer of Stomach 
* The testicular tissue was obtained from a 
normal organ removed during a herniorrhaphy. 
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Sodium acetate 
Sodium barbitone 
Sodium chloride 
0 .1 N. Hydrochloric acid 
Sodium azide 
9.714G 
14.714G 
17.0G 
500 ml. 
2.5G 
Plasminogen-rich fibrinogen : A 2% solution by weight of 
Bovine Plasma Fraction I (Armour)* was made in veronal 
buffer-saline, i.e. 0.2G dissolved in 10 ml. buffer-
saline, and this solution was filtered through cotton wool. 
* This preparation of bovine fibrinogen contains plasmin-
ogen and ·40-60% by weight of sodium citrate. 
Thrombin solution: Thrombin, Topical (Bovine Origin) 
(Parke Davis): stock solution 1,000 units/ml. in 50% 
0 glycerol, stored at 4 C. for a period not exc~eding 6 months. 
A working solution of 20 units/ml. in Michaelis buffer-
saline was made, i.e., by dissolving 0.1 ml. stock 
solution in 5 ml. buffer-saline, and this was stored at 
4°c. and discarded after one week. 
Cellophane sheet: "Cellophane PT", 300-400 gauge 
(British Cellophane Ltd.). 
Neutral buffered formalin solution: (Lillie, 1965). 
Harris?s haematoxylin: (Harris, 1900). No acetic acid 
should be .added, otherwise the fibrin will not stain well 
Special apparatus : A sheet of 6mm. thick plate glass, 
about / 
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about 60cm. X 45cm. in size, with three levelling screws. 
A Perspex frame, 20cm. X 14cm. X 0.2cm., with a central 
oblong aperture 16.3cm. X 6.0cm. Engineer's spirit 
level. Plastic boxes, approximately 32mm. X 22mm. ·' 
containing a square of damp plastic sponge, utilized 
as incubation chambers. (Messrs. Chanceis coverslip 
boxes are ideal). 
METHOD 
Storage of tissues: Samples of tissues from the male 
genital tract taken at necropsy were immersed in buffer-
saline. Blocks of prostate, taken immediately from the 
gland after prostatectomy, were immersed in tissue 
culture No. 1,99" , and also in buffer-saline, to provide 
a comparison between veronal buffer and tissue culture 
medium as preservative. These blocks of tissue were 
stored at 4°c. for 1-12 hours until an opportunity arose 
to "quick-freeze" the tissues. This was done by 
placing them in a small polythene bag, then plunging 
the bag into dry ice-acetone mixture. When frozen, 
they were stored in the deep freeze at -3o0 c. for 
periods of up to two months. 
made/ 
If sections were to be 
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made irrunediately, the tissues were frozen on the cryostat 
microtome chuck in the usual way. 
Tissue sections of 7-Su were cut on a Pearse cryostat 
microtome, and were applied to 32 x 22rrun. coverslips. 
The sections were allowed to dry at room temperature for 
about 30 minutes before application of the fibrin. 
Preparation of Autographs: The glass plate was levelled 
by means of the screws and the spirit level. The perspex 
frame was applied to the glass using a little buffer-saline 
to make it stick. A sheet of cellophane, pre-soaked in 
buffer-saline, was laid over the frame, and smoothed out 
over the glass exposed in the central space. Into the 
shallow bath so formeg, a clotting mixture consisting of 
3.5ml. fibrinogen solution and 0.2ml. of thrombin. This 
was allowed to clot, and the cellophane-backed fibrin 
sheet, which was approximately 0.4rrun. thick, was then cut 
into squares. A fibrin square was applied to each 
section. The tissue-fibrin preparations were then placed 
in separate incubation boxes, and incubated at 37°c. for 
either 15, 30 or 60 minutes. Two samples were taken from 
each perioa; thus 6 samples were examined from each block. 
Fibrinolyt·ic/ 
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Fibrinolytic activity was arrested by immersing the 
autographs in buffered formal-saline. After about 1 
minute in fixative, the cellophane sheet was stripped off, 
leaving the fibrin and the section adhering to the cover-
slip. The preparations were next stained (see below) and 
mounted for microscopy. Whenever the section contained 
activator, the plasminogen in the overlying fibrin was 
converted to plasmin, and the fibrin was digested. Micro-
scopic examination of these preparations now reveals the 
areas of digestion as pale gaps in the fibrin background, 
and these may be related topographically to structures in 
the overlying section (see Fig. 1). 
The degree of fibrinolytic activity of blood vessels, 
~-glands, ducts and secretion at 15, JO and 60 minutes was 
assessed, using a system of grading modified from that of 
Pandolfi, Nilsson, Rob~rtson and Isacson (1967). 
The activity was scored for each preparation as 
follows: 
activity detectable with naked eye 
activity only detectable using a 
10 X magnifier 
activity only detectable micro-
scopically at magnification X 100 
For/ 
• • • • • • • 3 
• • • • • • • 2 
. . . . . . . 
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Fig. l: The Construction of a Fibrinolysis Au tograph 
FROZEN SECTION 
:-~:~ ::: .. =.::·-:.:::.:-;.-::)::·-i·::.\'·).·{t-::· F 
lli!ill:1~•111:1:i'll!li s 
Sl ide 
-------
INCUBATE 
L1 
FIX and STAIN 
L1 
For each tissue component, the arbitrary units 
derived from the 6 samp .les were summed, .and this value 
represents the fibrinolytic activity for that component. 
Adjacent frozen sections taken at the commencement 
and completion of sectioning the tissue block, were placed 
on clean glass slides, allowed to dry, and then stained 
with/ 
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with haematoxylin and eosin (see below); the appearances 
of these were compared with the autographs to ensure that 
a representative sample had been tested. The appearances 
of those sections made from the enucleated prostate glands 
" were compared with the surgical pathologist~ routine 
report made on the remainder of the gland. 
Method of Staining Fibrinolysis Autographs 
1. The fibrin-slide preparations were left overnight in 
formal-saline. (Messrs. Chance's coverslip boxes 
make ideal containers). They were then: 
2. Washed in distilled water. 
3. Stained in Harrisis haematoxylin for 20-30 minutes. 
4. Differentiated overnight in gently running tap water. 
5. Washed with distilled water. 
6. Dehydrated in 70-80% Ethyl Alcohol for 30 minutes. 
7. 
8. 
9. 
Placed in Methylated Spirits for 30 minutes. 
10. 
1 1 • 
Placed 
Placed 
Cleared 
Placed 
in Absolute 
in Absolute 
in Xylene I 
in Xylene II 
12. Mounted in D.P.X. 
The/ 
Alcohol I overnight. 
Alcohol II for 30 minutes. 
for 30 minutes. 
for 30 minutes. 
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The scheme was later shortened and modified, without 
any apparent change in the quality of the stain. After 
the autographs had been left overnight in fixative, they 
were: 
1. Placed into running tap water for 10 minutes. 
2. Harris 1 s haematoxyljn for 20-30 minutes. 
3. Running tap water - 15 minutes. 
4. Methylated Spirits - 15 minutes. 
5. Ammoniated Absolute Alcohol - overnight. 
6. Absolute Alcohol - 3 hours. 
7. Xylene for 30-60 minutes. 
8. Mounted in D.P.X. 
Routine histological slides of the tissues were 
prepared in the following manner: 
1 • 
- 2. 
3. 
, ... 
5. 
6. 
7. 
8. 
Sections were fixed in 5% Acetic Acid in Absolute 
Alcohol for 5-10 minutes. 
Dipped into 70% Ethanol. 
Stained in Harris's haematoxylin for 30-60 seconds. 
Excess stain washed off in running tap water. 
"Blued" in Ammoniated Alcohol for 15-30 seconds. 
Washed with Absolute Alcohol. 
Counter stained with Eosin for 30-60 seconds. 
Washed/ 
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8. Washed with Absolute Alcohol. 
9. Washed with Xylol. 
10. Mounted in D.P . X. 
Some pitfalls encountered when preparing Fibrinolysis 
Autographs: 
During Cryotomy of the tissue block* 
(1) The tissue block may detach itself from the 
microtome chuck, because insufficient water has been 
used in mounting the block, or because the surface of 
the chuck is dirty or greasy. 
(2) Because the tissue block is too cold, causing 
it to become brittle, horizontal cracks may appear in 
the section, or the tissue may shatter during cutting 
These difficulties may be overcome by blowing a few puffs 
of warm air through a glass tube on to the face of the 
block. 
(3) Vertical scores or lines may be produced in the 
section by nicks in the cutting edge of the knife; by 
ice or frozen tissue adhering to the edge or face of the 
guide plate; or by hard calcified particles in the 
tissue block. 
*(For fullest details concerning fault diagnosis, see 
page/ 
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page 68 of the working manual for the "Pearse" Cold 
Microtome (Cryostat) Type H, second edition, published 
by the South London Electrical Equipment Co. Ltd. 1964.). 
During Preparation of the Fibrin film 
(1) After the fibrinogen solution has been allowed to 
clot within the Perspex frame, the ideal result is to 
obtain an opaque fibrin film. Inspection of the progress 
of fibrinolysis during incubation will reveal. the areas 
of lysis as translucent zones in the layer of fibrin. 
If the fibrin film remains transparent, this may be 
avoided by altering the ionic strength of the buffer-
saline used to dissolve the fibrinogen, viz. add l-2ml. 
distilled water to the fibrinogen, and make up to 10ml. 
with the buffer-saline. If this device is unsuccessful, 
an alternative ruse is to use only 0.1ml. Thrombin solution 
to clot the fibrinogen. 
(2) The cellophane-backed fibrin film should be 
immersed only for a moment in the formal-saline, other-
wise it will adhere to the fibrin too firmly to be 
peeled off. If this should happen,the fibrin-slide 
can still be stained in the usual way, without removing 
the cellophane. 
During Staining of the Autograph/ 
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During Staining of the Autograph 
After fixation of the section, the formal-saline 
should be thoroughly washed out of the fibrin-slide, 
otherwise, because of the acidity of the fixative, a 
reddish rather than a blue colour may occur, after 
staining with haematoxylin. The final preparation 
may contain opaque areas due to insufficient dehydration 
by alcohol, or insufficient clearing by Xylo~; it should 
then be thoroughly washed with alcohol, before undergoing 
further dehydration in spirits. 
Artefacts in the Preparation (from Todd, 1961) 
Areas of lysis in the autograph may be unrelated to 
overlying structures in the tissues. 
to: 
These may be due 
(1) If the Armour fibrinogen is not filtered, 
undissolved particles of fibrinogen will cause focal 
spontaneous lysis of the fibrin film. 
(2) Detached cells and loosely connected tissues, 
after digesting the fibrin, may float away during the 
subsequent manipulations. 
(3) The active parts of the section tend to sink 
below/ 
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below the level of the rest, and appear out of focus 
under the microscope. 
(4) Fat globules from the section may coat areas 
of the fibrin film and make these areas resistant to 
penetration by aqueous haematoxylin. These zones are 
due to failure of staining rather than to fibrinolysis. 
This artefact can be abolished if the preparation is 
defatted by immersion in spirits and then treated with 
Xylene, before staining. 
(N.B. The last two situations only apply to the method 
where the section is placed on the fibrin film, 
rather than on the coverslip.) 
CHAPTER V 
THE DISTRIBUTION OF 
PLASMINOGEN ACTIVATOR IN THE PROSTATE 
METHOD 
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PLASMINOGEN ACTIVATOR IN FRESH 
PROSTATIC TISSUE 
Blocks of tissue were taken from 25 glands 
immediately after enucleation prostatectomy, and 
immersed in tissue culture medium No. "199". In 
14 cases, blocks were also immersed in Michaelis 
buffer-saline, to provide a comparison between veronal 
buffer and tissue culture medium as a preservative. 
In 3 cases there was a carcinoma; the remaining 22 
glands showed benign fibromuscular glandulo-cystic 
hyperplasia. 
RESULTS 
The degree of fibrinolytic activity of blood 
vessels, glands, ducts and secretions at 15, 30 and 60 
minutes (with 2 preparations for each period) was summed, 
and this figure represents the fibrinolytic activity in 
arbitrary units for each tissue component (see Table 7). 
It is seen that the blood vessels have the greatest 
concentration of plasminogen activator, whilst moderate 
fibrinolysis arises from the epithelium of glands and 
ducts./ 
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ducts. The activity of the secretions was insignificant. 
No differenc e was detected betwee n the activity 
of adenomatous and carcinomatous sections. In the 
tissues immersed in veronal-buffer, the fibrinolytic 
activity was comparable to that seen in the tissues 
stored in tissue culture medium (see Table 8). The 
potency of plasminogen activator was unaffected by storage 
of the tissue blocks for periods up to 17 days (see 
Table 9). 
As before, fibrinolytic activity was always seen 
in relation to the blood vessels (see Figs. 2 - 5). 
Vascular activity was most striking in the fibromuscular 
stroma surrounding groups of glands (see Figs. 6,7), 
The adenomatous nodules were consistently ringed by 
foci of activity, where the vessels were sinuses often 
consisting only of endothelium. 
Fibrinolysis of a lesser degree than that around 
vessels, was seen in relation to the glands (see Figs. 
8,9), and ducts (see Fig. 10). The activity from these 
structures was infrequent and of haphazard distribution, 
most of the glands and ducts being inactive. The lysis 
was most pronounced where the epithelial lining was 
disrupted/ 
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disrupted, and was proportional to the number of 
detached cells (see Figs. 11 - 13). 
Secretion within the glands (see Figs. 8,14) or 
ducts was seldom active and lysis from it was seen in 
only 3 autographs. In a unique instance, activity 
was related to an inspissated mass of secretion (see 
Fig. 15). 
There was often increased activity at the edges 
of the section, where the tissue was most damaged. 
No fibrinolysis was seen related to collections of 
polymorphs. 
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Case To• Overall Vascular Glands Ducts Secretion Activity 
1 * 12 12 4 4 0 
2 6 6 0 0 0 
3 10 10 4 2 0 
4 12 1 2 4 0 0 
5 16 1 6 10 0 0 
6* 12 12 4 0 0 
7 16 16 0 0 0 
8 1 6 1 6 0 0 0 
9 1 6 1 6 1 2 12 0 
10 16 1 6 8 8 0 
1 1 1 6 1 6 8 8 6 
12 14 14 8 4 0 
13 1 6 16 10 6 0 
14 12 12 4 0 0 
15 18 18 8 0 2 
1 6 16 1 6 4 0 ' 0 
17* 8 8 6 0 0 
18 1 6 1 6 8 0 0 
19 1 6 16 8 8 0 
20 1 6 1 6 10 4 0 
21 1 6 1 6 8 0 0 
22 6 6 2 0 0 
23 10 10 0 0 0 
24 1 6 16 4 4 0 
25 10 10 2 0 0 
*Denotes Carcinoma 
Table 7: Distribution of Fibrinolytic Activity from 
Prostatic Tissue Components {arbitrary units) 
(Immersion in Tissue Culture medium No . 11 199") 
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Case No . Overall Vasc u lar Glands Ducts Secreti on Activity 
3 5 5 1 1 0 
4 6 6 2 0 0 
5 9 9 3 0 0 
6 * 6 6 1 0 0 
7 5 3 2 2 0 
9 8 8 4 5 0 
10 8 8 4 4 0 
1 1 7 7 3 3 0 
12 7 7 6 2 0 
13 8 8 5 5 1 
14 6 6 0 0 0 
15 9 9 0 0 0 
1 6 8 8 4 0 0 
17 * 4 4 3 0 0 
* Denotes Carcinoma 
Table 8 : Distrib u ti on of Fib r inoly tic Activity from 
Prostat i c Tis sue Components ( a r b i t r a ry u nits ) 
( I mmersion in veronal buffer-sali ne) 
- 83 -
Case Overall Duration Case Overall Duration 
No. Activity of Storage No. Activity of Storage 
1 12 2 hours 14 12 17 day s 
2 6 2 11 15 18 1 6 II 
3 10 2 11 1 6 1 6 2 hours 
4 12 6 11 17 8 24 11 
5 16 3 11 18 1 6 5 days 
6 12 3 11 1 9 16 24 hours 
7 1 6 5 days 20 16 3 days 
8 1 6 2 hours 21 1 6 3 11 
9 16 2 11 22 6 24 hours 
10 16 3 11 23 10 3 11 
1 1 16 5 11 24 16 9 days 
12 14 5 11 15 10 7 11 
13 1 6 2 11 
Table 9: Relationship of Fibrinolytic Activity to 
Duration of Storage 
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Fig. 2 
X 15 
30 mins. 
Figs. 2-5: Striking fibrinolytic activity consistently 
related to the blood vessels of the prostate. 
Note the areas of lysis occurring at the edges 
of the sections. (Final magnification and 
incubation period indicated). 
Fig. 3 
X 24 
60 mins. 
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Fig. 4: 60 mins. X 20 
Fig. 5: 60 mins. X 15 
Figs. 4,5: Prostate - impressive activity from blood vessels. 
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Fig. 6: 30 mins. X 15 
Zones of lysis arising from the blood vessels in the fibro-
muscular stroma surrounding groups of prostatic glands. 
Fig. 7: 30 mins X 24 
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Fig. 8 
X 24 
.30 mins. 
Areas of digestion arising haphazardly at various sites 
from the glandular epithelium. Several isolated areas 
of fibrinolysis occur within the secretions. 
Fig. 9 
X 95 
.30 mins. 
Higher magnification of an area of epithelial activity. 
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Fibrinolysis related to a group of ducts. 
An active prostatic duct, with maximum digestion 
related to detached epithelial cells. 
Fig .10 
X 95 
60 mins. 
Fig.11 
X 95 
30 mins. 
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Areas of digestion concentrated mainly around shed 
epithelial cells within the ducts. 
Fig.12 
X 95 
3o · mins. 
Fig . 13 
X 95 
30 mins. 
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Areas of fibrinolysis related to the epithelium and 
secretion of a gland. 
A prostati~ concretion or amylaceous body surrounded by a zone of fibrinolysis. 
Fig.14 
X 95 
30 mins. 
Fig.15 
X 240 
30 mins. 
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DISCUSSION 
Local tissue fibrinolysis may be enhanced by factors 
related to the surgical removal of the prostate. Indeed, 
increased fibrinolysis in the blood has been related to 
pre-operative anxiety (Macfarlane and Biggs, 1946); 
during general anaesthesia (von Kaulla, 1947); after 
trauma and ischaemia (Kwaan and McFadzean, 1956) ; during 
surgical procedures (Lynn Evans, 1964); and in the post-
operative period (Macfarlane, 1937). Wendt, Perlick and 
Seyffarth (1957) detected a greater level of fibrinolytic 
activity after prostatectomy when controlled hypotension 
was used, than when this technique was not employed. 
Although earlier studies have demonstrated a direct 
relationship between the number of leucocytes in the 
prostatic secretion from patients with chronic prostatitis, 
and the fibrinolytic activity of the fluid (Huggins and 
McDonald, 1944), in the autographs examined, no such 
topographical relationship to leucocytes was seen. 
It has been shown by Astrup and Permin (1947) that 
the fibrinolytic activity in human tissues is due to 
their ability to activate plasminogen. 
tissue/ 
Prostatic 
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tissue is rich in substances which can activate 
plasminogen (Rasmussen and Albrechtsen, 1960a), and 
it has been assumed that the increased fibrinolysis 
associated with abnormal bleeding in patients with 
disseminated prostatic cancer (Jtrgens and Trautwein, 
1930; Tagnon and others, 1952a, 1953a), or with 
benign prostatic hypertrophy (Andersson and Nilsson, 
1961), and also in prostatic surgery (Scott and others, 
1954; Lombardo, 1957; Baurys and Jacobson, 1959; 
Urlus, 1962), is due to the release of this activator 
into the blood stream (Fearnley, 1965). It has also 
been assumed that this activator is of epithelial 
origin and identical with the semen-liquefying 
protease (Huggins and Neal, 1942). 
In the light of these and other observations 
(Huggins and Vail, 194); Tagnon and others, 1952b, 
1953b; Scott, 1956), it is surprising that, with the 
histological technique, prostatic epithelium shows 
only slight ability to activate plasminogen. The 
present experiments do not support the view that 
fibrinolysis in prostatic disease could come from the 
glandular/ 
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glandular epithelium, and confirm the previous finding 
(Todd, 1961), that the bulk of the fibrinolytic 
activity of normal and carcinomatous prostatic tissue 
arises from the blood vessels. However, none of the 
cases in the present series showed a bleeding tendency, 
and until tissue from such haemorrhagic cases can be 
examined by fibrinolysis autography, the possibility 
remains that some types of prostatic epithelium, 
especially in carcinoma, may have a greatly increased 
activator content. 
It is equally likely that the bleeding in cases 
of metastatic prostatic cancer is a manifestation of 
disseminated intravascular coagulation (Seale, Jampolis 
and Bargen, 1951; Swan, Wood and Daniel, 1957). 
Rapaport and Chapman demonstraied in 1959 the presence 
of hypercoagulability and hypofibrinogenaemia in a 
case of disseminated prostatic carcinoma. Intra-
vascular clots have been shown at the autopsy of a 
similar case by Aggeler and Seale (quoted by Seale and 
others, 1951). It is known that the prostate is rich 
in thromboplastin (Seale and others, 1951; Swan and 
others, 1957; Benzer, Bl~mel and Piza, 1962), which 
may/ 
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may be released into the circulation when the cancer or 
its metastases are damaged or necrotic. Fibrinolysis 
would then follow as a secondary phenomenon. 
It has been shown that the level of circulating 
fibrinolysin in the blood of patients with cancer of the 
prostate, is significantly elevated above that detected 
in other urinary tract diseases, or in normal cases 
(Anglesio, Pelocchino and Bada, 1959; Mairano and 
Rigotti, 1960; Andersson, 1963a). Indeed, Tagnon and 
his colleagues (1953a) collected 48 cases of metastatic 
cancer of the prostate, of which 6 had a bleeding tendency 
due to abnormal fibrinolysis. Swan and Kerridge (1965) 
added to such controversy by finding no abnormal fibrin-
olytic activity in the blood of 68 patients with cancer 
of the prostate (of which 22 had metastases), when these 
cases were compared with those in a control group. 
The results also cast doubt on previous assumptions 
about the source of plasminogen activator in semen. 
Immediately after ejaculation, human semen coagulates, 
and this is followed within 20 minutes by liquefaction 
of the clots by a plasmin-like enzyme said to come from 
the I 
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the prostate (Huggins and Neal, 1942), although there 
is no direct evidence that this enzyme has come from 
prostatic epithelium. A semen-liquefying "fibrinolysin 1' 
has certainly been found in fluid obtained by prostatic 
massage (Huggins and Neal, 1942) but the reason for 
supposing that it came from the gland, rather than 
from the seminal vesicles, is not clear. There is 
evidence in the autographs to suggest that epithelium 
is more active when damaged and desquamated, so that 
prostatic massage may enhance the fibrinolytic activity 
of the secretory apparatus by the trauma it causes. 
The minor degree of fibrinolytic activity detected 
in prostatic epithelium seemed insufficient to account 
either for the fibrinolytic activity of semen, or for 
the haemorrhagic blood fibrinolysis seen in some cases 
of prostatic disease . It may be that either damage 
or stimulation of the epithelium is necessary to release 
the activator, or that seminal "activator1' comes from 
other sites in the male genital apparatus, in addition 
to that secreted by prostatic epithelium . 
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PART I 
REGIONAL FIBRINOLYTIC ACTIVITY 
On superficial inspection, the human prostate may 
appear uniform, but its various regions or so-called lobes 
are quite diverse in function (Mann, 1964). For instance, 
the predilection of prostatic carcinoma for the posterior 
region of the gland is well known , (Luck, 1965). The 
histological structure varies regionally, in that fibro-
muscular stroma predominates in the anterior region, the 
prostatic glands are situated chiefly in the lateral and 
posterior regions or lobes, and the excretory prostatic ducts 
are numerous deep to the urethral crest (vera montanum). 
The initial studies of the distribution of activator 
were on samples from adenomas or carcinomas which had been 
shelled out of the enclosing capsule. Because of the 
sampling from haphazard sites, and bearing in mind the 
regional histological variation, it seemed necessary to 
determine whether the distribution of activator could 
differ from region to region, by examining specimens taken 
from selected sites in the whole gland. 
METHOD/ 
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~TOOD 
Prostate glands were obtained from 10 necropsies, and 
blocks of tissue were taken from the anterior and -posterior 
regions of the glands, and from the area of the vera 
montanum. Fibrin-slide preparations were made, and the 
degree of activity was assessed (see Tables 10, 11 and 12). 
RESULTS 
No obvious regional difference in the overall 
intensity of fibrinolytic activity was detected in the 
samples taken from the anterior or posterior lobes, or 
from the vera montanum. However, the scores for the 
epithelial activity within the anterior lobe and the vera 
montanum were significantly higher than that attained by 
the glands and ducts in the posterior lobe. 
As before, it can be seen that the maximum activity 
was related to the blood vessels (Figs. 16, 17). 
Inconstant activity was related to the epithelium of 
glands (Figs. 17, 18 and 19) and ducts (Figs. 20, 21), 
and also to secretions and corpora amylacea (Fig. 22). 
, 
In the sections of 
commorv' 
vera montanum, 
. I zones of lysis were ' 
I 
- 99 -
common around the excretory and ejaculatory ducts (Fig. 23) 
approaching the urethral lumen, especially where the 
epithelium had been desquamated. In one particular 
prostate, taken from necropsy No. 13, the excretory ducts 
had been packed with amyloid bodies and calculi. A 
broad zone of lysis was related to the lining of one 
remarkably dilated duct (Fig. 24). 
When present, the urethral mucosa exhibited striking 
activity (Figs. 24, 25 and 26). In such samples obtained 
at necropsies, striated muscle fibres were often seen in 
the sections, and occasionally, these were related to small 
areas of lysis (Fig. 27). Damage or disruption enhanced 
the activity .of all the tissue components. 
/ 
I ' 
I 
TABLE 10: 
Necropsy 
No. 
5 
6 
7 
8 
9 
10 
1 1 
. 
1 2 
14 
Average 
TABLE 11: 
Necropsy 
No. 
5 
8 
9 
1 1 
1.3 
1 /,-
15 
!Average 
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Fibrinolytic Activity of Tissue Components in 
the Posterior Lobe of the Prostate 
Overall Vascular Glands Ducts Secretion 
Activity 
16 16 4 6 
1 , .. 14 6 6 
12 12 2 2 
16 16 10 6 
16 16 10 10 
16 16 9 7 
18 18 16 16 
16 16 10 10 
16 16 10 10 
16 16 9 8 
Distribution of Activity in the Anterior 
Lobe of the Prostate 
0 
2 
0 
0 
0 
2 
8 
2 
0 
2 
Overall Vascular Glands Ducts Secretion Activity 
1 6 1 6 0 2 0 
--1 6 16 16 16 0 
18 18 16 16 4 
16 16 16 1 6 16 
18 18 16 16 0 
16 16 6 6 0 
16 16 4 4 0 
17 17 1 1 1 1 3 
I 
I 
TABLE 12: 
Necropsy 
No. 
5 
6 
7 
8 
9 
10 
1 1 
1.3 
15 
Average 
.• 
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Activity of Tissue Components in the Vera 
Montanum 
l 
Overall Blood Glands Ducts Secretion 
Activity Vessels 
1 2 1 2 4 8 0 
1 6 16 10 10 0 
16 16 10 10 0 
16 16 6 6 0 
16 16 16 
-
1 6 0 
1 6 16 6 6 0 
16 1 6 16 1 6 12 
16 16 16 16 4 
18 18 14 14 0 
16 16 11 1 1 2 
/ 
I 
Fig. 16: 
Fig. 17: 
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Anterior lobe of prostate. Areas of lysis 
related to the blood vessels. 30 mins. X 19 
Vera montanum. Fibrinolytic activity arising 
from blood vessels, and also from the epithelium 
of large glands. 30 mins. X 24 
- 10.3 -
Fig. 18: Anterior lobe. 60 mins.X 24 
The glands show prominent zones of digestion throughout 
the sections. 
Fig. 19: Vera montanum. .30 mins. X 15 
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Fig. mins. X 122 
Fig. 21: 30 mins. X 95 
Figs. 20,21: Ducts in the anterior lobe of prostate 
exhibiting epithelial activity. 
Fig. 22: 
Fig. 2.3: 
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Vera montanum. Fibrinolysis arising from the 
secretions and inspissated material. JO minso X15 
Vera montanum. Epithelium of an ejaculatory 
duct surrounded by a wide area of digestion. 
30 mins. X 95 
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Fig. 24: Vera montanum. A ring of digestion arising from 
the glandular epithelium. Fibrinolysis also 
related to amylaceous material. JO mins. X 15 
Fig. 25: Urethral mucosa with a wide band of digestion. 
60 Mins. X 122 
Fig. 26: Vera montanum. .30 mins. X 95 
Prominent activity arising from urethral mucosa, especially 
where disrupted. 
Fig. 27: Anterior lobe of prostate. .30 mins. X 24 
Fig. 28: 
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Anterior lobe of prostate, with areas of 
digestion around striated muscle fibres. 30 mins. X 95 
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PART II 
THE ACTIVITY OF CORPORA AMYLACEA 
On many occasions in these studies, prostatic concre-
tions, corpora amylacea or amylaceous bodies had shown 
themselves to contain plasminogen activator. These bodies 
were round or oval in shape, and often consisted of 
concentric layers. A favourable opportunity arose to 
carry out further experiments on these bodies, when 
section of the prostate of necropsy No. 13 revealed that 
the excretory ducts leading to the urethra were packed 
with hundreds of corpora amylacea or calculi of all sizes, 
the largest being 1-2 mm. across. 
METHODS AND RESULTS 
Corpora amylacea and calculi were washed twice with 
Michaelis buffer-saline, and allowed to dry on filter 
paper. They were next divided into 3 lots, and from one 
portion, samples were placed separately on a layer of 
fibrin, and incubated using a low temperature technique 
developed by Todd and Nunn (1967). In this method, the 
sensitivity/ 
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sensitivity of the standard autograph can be greatly 
0 improved by exposure at 4 c. for 24-48 hours, followed 
either by immediate fixation, or incubation for 15-30 
minutes at 37°c. The fibrin-slide is next fixed. The 
more intense foci are damped down, while small foci, 
undetectable in the standard autograph, are strikingly 
'\ 
demonstrated. The explanation for this result may be 
that activation of plasminogen in the fibrinolysis auto-
graph proceeds at a similar rate at 4°c. or 37°c., while 
digestion of fibrin is rapid at 37°c. Naturally, during 
such a long exposure, pres~ vation of the tissue is better 
at 4°c. than exposure at room temperature or 37°c. 
TABLE 13: Fibrinolytic Activity of Corpora Amylacea 
Slide No. No. of Active Total No. of Corpora Corpora 
1 6 7 
2 13 1 9 
3 6 10 
4 7 8 
5 1 1 1 6 
6 8 17 
7 7 8 
8 18 20 
9 52 58 
10 5 7 
Total 133 170 
The/ 
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The corpora amylacea were exposed overnight (17 hours) 
at 4°c., followed by incubation for 60 minutes at 37°c. 
Most of these bodies were active (Fig. 29), and when 
counted, these formed 78% of the total (Table 13). 
The bodies and calculi of the second portion were 
ground to a fine powder, and suspended in 5 ml. compound 
Ringer's lactate solution to form a thick suspension • 
• 
Fig. 29: Digestion of fibrin by 5orpora amylacea. 
Exposure overnight at 4 C. X 5 
A drop of the suspension was spread out on a coverslip, 
and overlaid by a square of fibrin. Eight autographs 
were prepared 
surrounding/ 
all of these showed zones of digestion 
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surrounding the powdered amylaceous material (Fig. 30) 
after overnight exposure (17 hours) at 4°C., succeeded by 
0 
one hour at 37 c. 
The third lot of corpora amylacea was also ground to 
a fine powder, and portions weighing 0.2G. each were placed 
into equal volumes (2.0 ml.) of physiological saline, 
veronal-acetate buffer and 2M potassium thiocyanate. The 
mixtures were thoroughly stirred for several minutes, 
centrifuged, and the supernatant fluid was reserved. 
A 2M potassium thiocyanate solution by itself produces 
a marked zone of apparent 11 fibrinolysis 11 , in the presence 
of citrate (or phosphate) ions. This "citrate ion effect11 
(Mullertz, 1952) can be prevented by the addition of 
calcium ions, which bind citrate. However, the enhancing 
effect of citrate ions on plasminogen activator is thereby 
removed (Astrup and Sterndorff, 1960). Therefore, to 
neutralize the effect of potassium thiocyanate, about 
0.4 ml. of M/10 calcium chloride solution was added to 
J.5 ml. fibrinogen solution, before clotting with thrombin. 
It was confirmed in a set of control autographs that 
sufficient calcium had been added by testing the fibrin 
film with the potassium thiocyanate solution. 
A/ 
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A drop from each extract was placed on fibrin squares, 
. 
0 
and the autographs were exposed overnight at 4 c. as 
before. Every preparation showed evidence of fibrinolysis 
(Figs. 31, 32 and 33), but no significant diff~rence 
could be detected in the degree of activity produced by 
any of the extracts. Activator then appears to be 
fairly loosely bound in the corpora amylacea, whereas 
activator in the tissues is relatively insoluble. 
/ 
Fig. ]0: 
Fig.]1: 
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Fibrinolysis by powdered corpora amylacea.x 5 
Saline extract of corpora producing 
fibrinolysis. X 5 
- 115 -
Fig. J2: Fibrin-digestion by buffer-saline extract. X 5 
Fig. 33: ' Lysis by potassium thiocyanate extract. X 5 
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PART III 
FIBRINOLYSIS BY PROSTATIC IMPRINTS 
A block of freshly-obtained tissue from an 
enucleated prostate was pressed firmly against a glass 
slide. A slice of tissue was shaved off from the block's 
surface, and a further imprint was made. In this manner, 
21 imprints were made from 3 glands, obtaining specimens 
of detached epithelial cells, secretions and amylaceous 
bodies. Fibrin-slide preparations were exposed overnight 
at 4°c. 
Foci of fibrinolytic activity were related to these 
etached epithelial cells (Figs. 34, 35, 36 and 37), 
secretions (Fig. 36), and corpora amylacea (Figs. 38 and 
.39). 
Figs. 34 - 37: 
- 11 7 -
Prominent zones of digestion related to 
detached epithelial cells and amylaceous 
bodies. 
Figo 34 X 24 
Fig. 35 X 15 
Fig. 36: 
Fig. 37: 
- ns -
Apart from epithelial activity,there is a zone 
of lysis related to an area of dried secretions 
X 15 
X 24 
Figs • .38 - .39: 
' - 1Ji9 -
Broad zones of digestion surround these 
corpora amylacea. X 15 
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DISCUSSION 
The "corpora amylacea" or amylaceous bodies, usually 
located in the larger ducts and acini of the prostate, are 
small, soft, concentrically laminated spheroidal bodies, 
pale yellow to dark brown in colour, and frequently doubly 
refractile. They are made up of desquamated epithelial 
cells and prostatic secretion (Mann, 1964), and these 
- -
secretory products consist of proteins, including albumin 
and glpbulin (Wagner and Kim, 1963), mucoproteins and 
muc~polysaccharides (Smith, 1966). 
Prostatic calculi are firm calcified bodies, usually 
not more than a few mm. in diameter, and of the same 
basic structure as that of the corpora amylacea (Moore, 
1936), apart from their size, and the presence of calcium 
salts. The protein content of dry powdered calculi has 
been estimated to be about 8% (Huggins, 1947). A number 
of factors are responsible for the formation of prostatic 
calculi, viz. obstruction and dilatation of th~ prostatic 
ducts; urinary reflux and infection (Fox, 1963). There 
is a definite link between prostatic and urinary calculi, 
frequently related to hypercalciuria. 
It/ 
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It has been shown that plasmin degrades chondro-
mucoprotein by attacking the protein moiety, releasing a 
chondro-mucopolypeptide (Lack and Rodgers, 1958). This 
finding was confirmed by Charlton (1966, 1967) during 
experiments on dogs, and he demonstrated that the protein 
normally found in urine is a substrate for plasmin. He 
showed that diminished fibrinolytic activity of dog's 
urine resulted in a significant rise in the non-dialyzable 
solids, which predisposed to the development of a 
mucoprotein matrix or fibrinous calculus. He presented 
the hypothesis that the majority of urinary calculi develop 
in the presence of a dminished fibrinolytic activity in 
urine, if at the same time, a metabolic disturbance occurs, 
e.g. hypercalciuria or hyperoxaluria. Indeed, if the 
urine has normal fibrinolytic activity, but these metabolic 
disturbances prevail, then a stone will not form. 
It is feasible that the development of amyloid 
bodies is initiated by an alteration in the coagulation-
fibrinolysis balance, in favour of fibrin-deposition, 
analagous to thrombosis occurring within the blood vessels. 
Indeed, it has been shown that the gland is rich in 
thromboplastic substances (Benzer and others, 1962; Swan 
and/ 
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and others, 1965). In order to maintain the patency of 
the prostatic excretory system, it seems necessary that a 
fibrinolytic mechanism should be present to prevent 
fibrinous deposition around the innumerable detached 
epithelial cells, which themselves contain significant 
amounts of activator. 
Supplementary to the fibrinolytic system, a further 
factor helps to maintain the fluid state of semen and 
prostatic secretion. ~ Huggins and Neal (1942) discovered 
that samples of human prostatic fluid inhibited the 
clotting of human blood. Since coagulation of the blood 
proceeded normally when calcium chloride was added, they 
concluded that the high concentration of citrate in 
prostatic fluid (Huggins, Scott and Heinen, 1942} was the · 
cause of the prolonged coagulation time. 
A similar model of equilibrium to that found in the 
blood stream is seen in the urinary tract. Urine normally 
contains a thromboplastic material which contributes to 
haemostasis (Tocantins and Lindquist, 1947; von Kaulla, 
1956). Ladehoff (1960) thought that urokinase came from 
the urinary conducting tissue, released by the disintegr-
ation of the highly active epithelial cells lining the 
' 
conducting/ 
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conducting sections of the urinary tract. He demonstrated 
that desquamated urinary epithelial cells obtained by 
centrifuging the bladder urine of cadavers, had a high 
content of activator. Indeed, there exists a concept 
that urokinase maintains the patency of the urinary tract 
by lysing fibrinous deposits (Astrup and Sterndorff, 
1952b; Charlton, 1966, 1967), although it will impair 
haemostasis during urinary tract surgery (McNicol and 
others, 1961a). 
In view of these previous considerations, it occurred 
to me that a disturbance in the coagulation-fibrinolysis 
equilibrium of prostatic secretion could lead to the 
development of corpora amylacea. The following evidence 
is presented in support of my hypothesis. 
As with a clot in a blood vessel adsorbing fibrinolysin, 
it seemed necessary to determine whether the protein of 
corpora amylacea could adsorb activator from the surround-
ing medium. It has been demonstrated, too, that the 
mucoproteins of urine adsorb urokinase, and indeed, 
5-15 ml. of urine has enough activator to dissolve 1 ml. 
of blood clot (von Kaulla, 1960). A collection of 
amy laceo.us / 
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amylaceous bodies, freshly obtained from an enucleated 
prostate, were washed twice with Ringer-lactate solution, 
and divided into 2 equal lots. One portion was placed 
in a sterile screw-topped jar containing 20 ml. sterile 
fresh urine. The second portion was placed in a similar 
volume Ringer's solution to act as a control. The 
containers were stored for 48 hours at 4°c. The corpora 
were next washed thrice with Ringer's solution to remove 
all traces of the storage solutions. Fibrinolysis 
autographs were made with the corpora, and were exposed 
at 4°c. for 24 hours, followed by incubation at 37°c. for 
60 minutes. Autographs were made from drops of the 
stored urine and Ringer's solution. 
The results (see Table 14) demonstrated that urine 
was rich in activator (Fig. 40) and that the Ringer's 
solution had extracted a significant quantity of activator 
from the corpora (Fig. 41). Of the corpora amylacea 
steeped in urine, about 50% were active (Fig. 42), while 
about 26% of those kept in the Ringer's solution (Fig. 43) 
digested fibrin. Because plasminogen activator appears 
to be loosely bound to corpora amylacea, extraction of 
activator by the Ringeris solution could contribute some-
what/ 
,, 
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what to the lower level of activity exhibited by the 
controls. However, the same factor would apply to 
corpora soaked in urine. 
It has been demonstrated that prostatic amyloid 
bodies can adsorb plasminogen activator, just as a mural 
thrombus in a blood vessel adsorbs activator from 
circulating blood (Fearnley, 1961). The effect of 
absent seminal fibrinolysins is demonstrated in rodents, 
where retrograde ejaculation into the bladder results in 
the formation of coagulated cheese-like lumps (Clayton 
and others, 1956; Vulp~ and others, 1956). 
Further indirect evidence in support of my hypothesis 
is the finding by Moore (1936) that corpora are most 
abundant in the "cephalad" portion of the posterior lobe, 
and in the larger ducts and adjacent acini of the lateral 
lobes. They are infrequent in the middle lobe, and rare 
in the anterior lobe. These discoveries bear relation 
to the findings of the present studies, that the fibrin-
olytic activity of the ducts in the postero-lateral 
regions of the prostate is less than the duct activity in 
the anterior lobe and the vera montanum. 
It I 
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It would be very interesting to know whether the 
development of amylaceous bodies in the acini can be arrested 
or reversed by fibrinolysis. Vulpe and others (1956) 
believe that, in rodents, dissolution of the bladder 
masses by the action of urine, occurs as a normal physio-
logical process. Corpora within an infected ,acinus are 
subsequently digested by the fluid of the exudate (Moore, 
1936), and corpora involved in an area of caseous necrosis 
undergo rapid dissolution. There is evidence that the 
secondary softening which corpora undergo, is brought 
about by proteases (Moore and Hanzel, 1936). 
Although characteristic of the human prostate, corpora 
amylacea are also found elsewhere in the animal kingdom, 
particularly among insectivores where they form the 
principal secretory product of male accessory organs 
(Eadie, 1948). Their presence. in seminal plasma 
contributes substantially to the final consistency of the 
copulatory plug by giving "body" to the mass, and they 
are digested when the copulatory plug liquefies. 
In order to find additional support for my hypothesis 
concerning the development of corpora amylacea, an 
investigation / 
investigation is under way at present, to determine by 
means of electron microscopy whether the amylaceous 
bodies contain fibrin fibrils. Marx, Gueft and Moskal 
(1965) studied the structure of corpora amylacea by means 
of electron microscopy. The bodies consisted of branch-
ing, double-stranded fibres with banding, 200-JOOA in 
breadth. They also contained fine granules and amorphous 
material. These granules are thought to be secretory 
products of the epithelial cells. The significant 
feature was that the fibrils did not resemble amyloid in 
several respects. 
TABLE 14: Fibrinolytic Activity of Corpora Amylacea 
steeped in Urine and Ringer's Solution 
Slide Corpora Steeped in Urine Corpora Steeped in Ringeris 
No. Active Total Active Total 
1 2 4 3 9 
2 4 18 4 9 
3 2 6 2 6 
4 6 1 6 0 4 
5 12 12 2 7 
6 6 8 0 8 
7 6 1 1 2 8 
Total 
.38 75 1.3 51 
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Fig. 40: Impressive digestion by a drop of the urine in 
which corpora amy6acea had been steeped. §xposure for 24 hours at 4 c., then 60 mins. at 37 C. X 5 
Fig. 41: Lysis by a drop of the Ringer's solution in 
which amylaceous bodies had been steeped. X 5 
Fig. 42: Frequent areas of fibrinolysis by corpora. 
amylacea which had been steeped in urine. X 5 
Fig. 43: Less frequent zones of lysis by corpora 
amylacea after storage in Ringerts solution. X 5 
CHAPTER VII 
FACTORS INFLUENCING THE SENSITIVITY 
OF PLASMINOGEN ACTIVATOR 
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FACTORS INFLUENCING THE SENSITIVITY OF 
PLASMINOGEN ACTIVATOR IN THE PROSTATE 
Using the histochemical technique, it has been 
confirmed that the vascular endothelium has abundant 
plasminogen activator. It has also been revealed that 
the glandular epithelium. contains an inconstant amount of 
tissue activator. It seemed relevant, then, to determine 
whether the sensitivity of prostatic activator would 
alter by varying the conditions of storage, and by 
adjusting the make-up of the substrate. 
(1) Effect of Storage on the Stability of Activator 
METHOD 
Three blocks of tissue were taken from each of 4 
prostate glands, immediately after surgical removal. A 
block from each gland was mounted on a microtome chuck, 
wrapped up .well in Gallenkamp's "Parafilm", and stored 
continuously at -30°C. in carefully closed polythene bags. 
At least two fibrin-slide preparations, incubated for 
60 minutes at 37°c., were made from each of these samples . 
after specific intervals of storage, viz. 24 hours, 1 week, 
1 month, 2 months, 4 months, 6 months, 9 months and one 
year. / 
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year. The degree of overall activity of the components 
in both slides was assessed after each interval, the 
scores summed, and the results of all the stages were 
compared to see whether any difference could be determined. 
RESULTS 
It can be seen from the scores in Tables 15 - 18, 
that the levels of activity fo~ ·the components remained 
undiminished after one year's storage. Figs. 44, 45, 46 
arid 47 show the topography of fibrinolysis autographs 
made after 24 hours, 2 months, 6 months and one year's 
storage. 
It has been shown that tissue activator can remain 
stable for long periods. Indeed, tissue activator stored 
0 as a dry powder at -20 C. has remained stable for up to 
18 months (Albrechtsen, 1959). The possibility that 
warmer temperatures could affect the stability of 
activator was next examined. 
In order to simulate the usual conditions of storage 
of a cadaver prior to a necropsy, the two remaining blocks 
of prostatic tissue were processed in the following 
manner. Immediately after prostatectomy, the two blocks 
were/ 
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TABLE 15: Sample 1 - Fibrinolytic Activity in Prostatic 
Tissue after Storage 
Duration Overall Vascular Glands Ducts Secretion 
of Stora~e Activity 
24 hours 6 6 4 6 0 
1 week 6 6 4 6 0 
1 month 6 6 4 6 2 
2 months 6 6 4 6 4 
4 months 6 6 4 4 2 
6 months 6 6 4 4 0 
9 months 6 6 6 4 2 
12 months 6 6 6 4 4 
, 
TABLE 16: Sample 2 - Fibrinolytic Activity after Storage 
Duration Overall Vascular Glands Ducts Secretion of Stora~e Activitv 
24 hours 6 6 2 2 0 
1 week 6 6 4 4 0 
1 month 6 6 4 4 2 
2 months 6 6 4 4 2 
4 months 6 6 4 4 2 
6 months 6 6 4 4 0 
9 months 6 6 4 4 0 
12 months 6 6 6 4 4 
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TABLE 17: Sample 3 - Fibrinolytic Activity after Storage 
Duration Overall Vessels Glands Ducts Secretion of StoraR"e Activity 
24 hours 6 6 4 4 0 
1 week 6 6 4 4 0 
1 month 6 6 4 4 0 
2 months 6 6 4 2 0 
4 months 6 6 4 2 0 
6 months 6 6 4 4 0 
9 months 6 6 4 4 0 
12 months 6 6 4 4 0 
TABLE 18: Sample 4 
Duration Overall Vascular ·Glands Ducts Secretion of Stora-'!e Activitv 
24 hours 6 6 4 4 0 
1 week 6 6 4 4 0 
1 month 6 6 0 0 0 
2 months 6 6 2 2 0 
4 months 6 6 4 4 0 
6 months 6 6 4 4 0 
9 months 6 6 2 2 0 
12 months 6 6 4 4 0 
Fig. 44: 
Fig. 45: 
- 1.35 -
Fibrinolysis in prostatic tissue after its 
storage for 24 hours. 60 mins. X 15 
Appearance of autograph from tissue stored for 
2 months. 60 mins. X 19 
Fig. 46: 
Fig. 47: 
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Foci of lysis in prostatic tissue stored for 
6 months. 60 mins. X 19 
Fibrin-slide made from tissue stored for 
12 months. 60 mins. X 19 
-- 1.3 7 -
were inunersed in buffer-saline, and one, acting as a 
control sample, was quick-frozen within the hour, and 
stored at -;o0c. The second block was kept in buffer-
saline at room temperature for about 6 hours, followed by 
storage at 4°c. for 18 hours. From the prostate of Case 
No. 4, a further block was taken, placed in a capped 
plastic container, and left unpreserved by buffer-saline 
at room temperature for about 24 hours. At least two 
fibrinolysis autographs were made from each of these 
tissue blocks. 
That the tissue activator is extremely stable, is 
supported by the finding that no significant difference , in 
the degree of activity from these samples was detected 
(Table 19). Figs. 48, 49 and 50 show that the distribu-
tion of fibrinolysis is comparable under the different 
conditions of storage, although the zones of digestion 
in the autolysing, unpreserved tissue tended to become 
confluent, and were often too diffuse to localize precisely 
to a particular tissue component. 
' . 
. 
.. 
:· 
•· 
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TABLE 19: arison of Fibrinol tic Activit of 
Tissues with Postmortem PM 
Case Method Overall Vessels Glands Ducts Secretion No. Activity 
' 
"Fresh" 6 6 4 6 0 
1 
"PM" 6 6 4 4 0 
"Fresh" 6 6 4 2 0 
2 
"PM" 6 6 6 '6 0 
"Fresh" 6 6 4 4 4 
.3 
"PM" 6 6 4 4 0 
"Fresh" 6 6 4 4 0 
4 II PM" 6 6 4 4 0 
"Unpreserved" 6 6 4 4 0 
Fig. 48: 
Fig. 49: 
- 1.39 -
Fibrinolysis autograph made from "fresh" 
prostatic tissue. 60 mins. X 24 
Zones of digestion in prostate after 
"cadaveric" storage. .30 mins. X 24 
Fig. 50: 
- 140 -
Foci of activity in degenerating prostatic 
tissue, left unpreserved for 24 hours. 
60 mins. X 24 
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(2) Human Fibrin as a Substrate 
As prostatic epithelium shows only moderate ability 
to activate plasminogen, it may be that plasminogen-rich 
bovine fibrin is an unsuitable substrate for the semen-
liquefying factor. If fibrinolysis autographs are 
prepared using human fibrin, it seemed likely that greater 
activity could be detected in the glandular epithelium. 
This possibility was examined using standard freeze-dried 
human fibrinogen*to make the fibrin film. 
Tissue sections were cut from blocks taken from 5 
glands removed at prostatectomy, and autographs were made 
using human fibrinogen, incubating the preparations for 
60 minutes. A control series of autographs was made 
incorporating bovine fibrin. The fibrin films obtained 
after clotting the human fibrinogen with thrombin were 
stickier, less firm , and more translucent than the 
bovine fibrin films. The scores for the overall activity 
of 2 preparations from each gland were summed (Table 20). 
Apart from Case No. 3, .where no activity was seen in 
the human fibrin autographs, the overall degree of 
fibrinolysis from each substrate was similar. 
the/ 
* Cohn Fractionl (cold-ethanol-precipitated) 
However 
TABLE 20: 
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Comparison of Overall Activity from Human 
and Bovine Fibrin 
Case Human Bovine 
No. Fibrin Fibrin 
1 4 4 
2 4 4 
3 0 4 
4 6 6 
5 6 6 
the zones of digestion were noticeably more numerous in 
the bovine fibrin preparations, (Figs. 51 and 52). 
Standard freeze-dried human fibrinogen is deficient 
both in citrate and plasminogen, and these reasons account 
for the slight difference · in favour of the bovine fibrin 
preparations. 
Fig.51: 
Fig. 52: 
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Control autograph of prostatic tissue using 
bovine fibrin. 60 mins. X 24 
Zones of fibrinolysis in fibrin-slide made 
with human fibrin. 60 mins. X 24 
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Fig. 53: No evidence of digestion when heat-denatured 
fibrin is incorporated in the autograph. 60 mins X 24 
Fig. 54: Control autograph using unheated fibrin. 
60 mins. X 24 
146 -
TABLE 21: Fibrinolysis in Autographs made from Heated 
and Unheated Fibrin 
Case No. 1 2 3 4 5 6 7 
~ Heated 
Fibrin 0 0 0 0 0 0 0 
Unheated 6 6 6 6 6 6 6 Fibrin 
Lassen's method of heat denaturation of plasminogen 
in fibrin renders the fibrin insensitive to fibrinolytic 
activators, while the sensitivity to proteolytic enzymes 
is partly retained. Even though the oven is pre-heated 
to 70 - so0c. for 60 minutes, and allowing for a brief 
drop in temperature when the oven door is opened, traces 
of plasminogen can still be left in the fibrin (Brakman, 
1967). 
The change in character of the heated fibrin becomes 
apparent when it is stained with Harris's haematoxylin. 
The intensity of the blue stain is of a lighter shade than 
that obtained using unheated fibrin, and this factor can 
make the identification and subsequent photomicrography 
of pale zones of lysis a little more difficult. 
Heating/ 
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Heating also denatures the fibrin causing changes in 
sensitivity to some enzymes. Therefore, for these reasons, 
in order to distinguish between proteolytic enzymes and 
plasminogen activators, it would be better to use fibrin-
ogen which is free of plasminogen (Brakman, 1967), and 
this preparation is now available. 
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(4) The Effect of Epsilon-Amino-Caproic Acid (EACA) 
EACA is a potent inhibitor of plasminogen activator 
at a concentration of 10-~, and in greater strength, it 
will inhibit plasmin. It has been employed successfully 
in the treatment of pathological hyperfibrinolytic states. 
The effect of EACA on fibrinolysis by prostatic tissue 
was examined. 
A stock solution of EACA (molecular weight of 161) 
-2 6 of a strength 2 X 10 M was prepared by dissolving 0.2 2G 
powder in 100 ml. normal saline. A working solution of 
2 X 10-4M was prepared, and a sheet of bovine fibrin was 
soaked in a shallow bath of this solution for about 2 hours. 
~~ Fibrinolysis autographs were made with the EACA-
treated fibrin, using tissue taken from 6 enucleated 
prostate glands. Duplicate preparations were incubated 
for 60 minutes, and the results were compared with the 
activity seen in the control slides made from standard 
fibrin. 
In all instances, there was a reduction in the degree 
of fibrinolytic activity in the EACA-treated autographs, 
both from the blood vessels and the glands (see Table 22). 
The/ 
- 149 -
The number of zones of fibrinolysis was distinctly reduced 
in these preparations, when compared with the controls 
(Figs •. 55 and 56). 
TABLE 22: 
Case No. 
EACA and 
Fibrin 
Control 
Influence of EACA 2 X 10-4M on Prostatic 
Fibrinolysis 
1 2 3 4 5 6 
4 0 4 4 4 4 
6 4 6 6 6 6 
As the effect of such an inhibitor is related to the 
conc·entrations of inhibitor and activator, a sheet of 
fibrin was soaked in EACA solution of 2 X 10-2M strength. 
All fibrinolytic activity was completely inhibited in 
autographs~ncorporating .such a fibrin film. 
Fig. 55: 
Fig. 56: 
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Control autograph of prostatic tissue. 
60 mins. X 24 
Inhibition of fibrinolysis by epsilon-amino-
caproic acid. 60 mins. X 24 
CHAPTER VIII 
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PLASMINOGEN ACTIVATOR IN TESTICULAR TISSUE 
Fibrin-slide preparations were made from 13 specimens 
of testicular tissue, of which one sample was from a 
surgically excised gland. The fibrinolytic activity was 
assessed in arbitrary units (Table 23), and seve~al 
significant features were noticed. 
The overall activity was quite inconspicuous (Figs. 
57 - 60). The tunica albuginea is a relatively avascular 
fibrous covering, and the few blood vessels seen showed 
only little activity after 15 - 30 minutes incubation 
(Fig. 57), wh~n compared with that related to prostatic 
capsular vessels. The areas of digestion after 60 minutes 
was more striking (Figs. 58, 59). The parenchymal 
vessels, sparse in number, had noticeable areas of 
digestion, too, after the longer periods of incubation 
(Fig. 60). 
Zones of lysis related to the seminiferous epithelium 
(Figs. 61, 62) were most uncommon despite a careful search, 
and these zones were particularly related to areas of 
tissue disruption (Figs. 63, 64 and 65). No fibrinolytic 
activity whatsoever arose from the spermatozoa within the 
lumina of the/ 
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of the seminiferous tubules, and none was seen related to 
the interstitial cells of Leydig. 
TABLE 23: 
Necropsy 
No. 
3 
4 
5 
6 
7 
8 
9 
10 
1 1 
12 
13 
14 
15 
Aver:-age 
Fibrinolytic Activity of Testicular Tissue 
Components. 
Overall Vascular Epithelium Spermatozoa Activity 
10 10 0 0 
12 12 0 0 
12 12 0 0 
12 12 0 0 
12 12 0 0 
12 12 0 0 
16 16 0 0 
16 16 6 0 
14 14 3 0 
16 16 2 0 
14 14 0 0 
12 12 0 0 
10 10 1 0 
13 lJ 1 0 
Fig. 57: 
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fibrinolysis are 
The seminiferous 
this duration of 
Testis - insignificant areas of 
related to the blo9d vessels. 
tubules are quite inactive at 
incubation. 15 rnins. X 24 
Figs. 58 and 59: 
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60 mins. X 15 
Zones of digestion related to blood 
vessels, mainly those in the tunica. 
The seminiferous tubules are inactive. 
60 mins. X 19 
Fig. 60: 
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Fibrinolysis arising from the parenchymal 
vessels. 60 mins. X 15 
Figs. 61 - 65: Lysis is seen related to the seminiferous 
epithelium, particularly to damaged areas 
in Figs. 6J - 65. 
Fig. 61 
60 min~ 
Fig. 62 60 mins. X 95 
Fig. 63: 30 mins. X 122 
157 
Testis. 
Testis. 
Fig. 64: 60 mins. X 152 
Fig. 65: 30 mins. x 95 
158 -
Testis 
Testis 
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FIBRINOLYTIC ACTIVITY OF THE EPIDYDIMIS 
The epidydimis was ~issected from each of 11 testes, 
and from each organ, tissue samples were taken both from 
the head and from the distal portion of the body. Fibrin-
slide preparations were constructed, and the fibrinolytic 
activity arising from the head of the epidydimis was 
compared with that of the body of the organ, to see 
whether any distinction could be determined. 
It can be seen that the activity of the tissue 
components from the proximal and distal portions of the 
organ appeared the same (Tables 24 and 25). Consistent 
and well-marked zones of fibrinolysis were related to the 
~ blood vessels throughout the sections (Figs. 66,67). 
Their activity was often so extensive, that the generally 
inactive tubules stood out prominently as blue-staining 
islands, encompassed by wide zones of digestion. Fig. 68 
shows impressive fibrinolysis related to the endothelial 
lining of an arteriole, from which several of the 
endothelial cells are detached. 
Epithelial activity was random in distribution, and 
only of moderate intensity (Fig. 69 and 70). The search 
for I 
w 
If 
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TABLE 24: Fibrinolytic Activity of Tissue Com12onents ,. 
... of Head of EQidydimis :, 
t ;; 
,., 
'" Necropsy Overall '· 
No. Activity Vascular Epithelium Secretions ,.. ·, 
•' 
5 16 16 3 0 
6 16 16 3 0 ( 
7 10 10 0 '.' 
'.) ; 
" 8 16 16 2 0 
9 16 16 4 0 
:.•, 10 16 16 10 0 r 
r i 1 1 18 18 10 0 "· .. · . 
" 
.. 
12 1 6 16 10 0 .. 
" 
13 16 1 6 10 0 
., 
;·. 
' 16 16 14 7 C 
" 
. 
15 18 18 6 0 s 
. 
" Average 16 16 
\ 
6 0 ; 
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TABLE 25: 
Necropsy 
No. 
5 
6 
7 
8 
9 
10 
1 1 
12 
1.3 
14 
15 
Average 
' ' 
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Fibrinolytic Activity of Tissue Components 
of Body of Epidydimis. 
Overall Vascular Epithelium Secretions Activity 
1 6 16 2 0 
16 16 6 0 
12 12 0 0 
1 6 1 6 2 0 
16 16 7 0 
16 16 9 0 
1 6 1 6 6 0 
16 16 (J)Q 0 
18 18' 14 0 
16 16 0 0 
18 18 4 0 
16 16 5 0 
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for isolated areas of epithelial activity was impeded by 
prominent overlap of the tubules by vascular fibrinolysis. 
The spermatozoa and secretions exhibited no evidence of 
fibrinolytic power (Fig. 71). 
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Fig. 66: Head of Epidydimis. 60 mins. X 15 
Prominent zones of fibrinolysis localized to the blood 
vessels. 
Fig. 67: Body of Epidydimis. 30 mins. X 15 
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Fig. 68: Arteriole in the head of the epidydimis, with 
areas of lysis related to the endothelial cells; 
especially where these have been detached. 60 mins. 
X 95 
Fig. 69: Body of epidydimis, with activity related to the 
tubular epithelium. 60 mins. X 122 
l 
Fig. 70: 
Fig. 71: 
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Head of epidydimis showing fibrinolysis 
localized to a group of tubules. 60 mins. 
Head of epidydimis - no activity related to 
spermatozoa or the secretion. 60 mins. X 475 
CHAPTER X 
LOCALIZATION OF ACTIVATOR IN THE 
VAS DEFERENS 
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LOCALIZATION OF ACTIVATOR IN THE 
VAS DEFERENS 
In 14 cases, fibrinolysis autographs were made from 
samples of the main trunk of the vas deferens. Fibrin-
slide preparations were made, in 9 cases, from the duct's 
dilated termination - the ampulla of the vas deferens. 
The fibrinolytic activity of these two regions of the vas 
was assessed in arbitrary units (Tables 26 and 27), and 
the results obtained for both regions were compared. 
In both regions, the blood vessels exhibited uniform 
and impressive activity (Figs. 72 and 73), particularly 
those that were sinusoidal. Fig. 74 shows considerable 
activity related to a thin-walled vein, while the adjacent 
artery is inactive. Epithelial activity was random in 
distribution and moderate in intensity (Figs. 75, 76), but 
such fibrinolytic activity was especially enhanced where 
the cells had been torn off from their attachments (Figs. 
77, 78). 
Using the semiquantitative method of evaluation, 
it is shown that the concentration of plasminogen activator 
in the epithelium remains constant in the proximal and 
distal/ 
. TABLE 26: 
Necropsy 
No. 
1 
2 
3 
5 
6 
7 
8 
9 
10 
1 1 
12 
13 
14 
15 
Average 
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Fibrinolytic Activity of Vas Deferens 
Tissue Components 
= 
Overall Vascular Epithelium Secretions Activity 
8 8 0 0 
1 6 16 12 0 
16 16 6 0 
16 16 0 0 
10 10 4 0 
16 16 6 0 
1 6 16 12 0 
12 ·12 6 0 
1 6 16 6 0 
1 6 16 6 0 
12 12 6 0 
18 18 10 0 
1 6 16 12 0 
16 16 6 0 
15 15 7 0 
TABLE 27: 
Necropsy 
No. 
5 
6 
7 
8 
1 1 
12 
13 
14 
15 
Average 
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Fibrinolytic Activity of Tissue Components 
of the Ampulla of Vas Deferens 
Overall Vascular Epithelium Secretions Activity 
12 12 6 0 
' 12 12 4 0 
12 12 0 0 
16 1 6 6 0 
18 18 14 0 
10 10 6 0 
16 16 10 0 
16 16 10 0 
16 16 10 0 
14 14 7 0 
distal portions of the vas deferens. Fibrinolysis was also 
noticeable at the edges of the sections where damage was 
likely. Scattered foci of digestion were related to the 
smooth muscle fibres in the wall of the vas (Fig. 79). 
No activity arose from the secretions. 
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Fig. 72: Vas deferens. JO mins. x 15 
Fibrinolysis related mainly to small blood vessels, but 
the epithelium also shows haphazard activity; Figs. 72, 73 
Fig. 73: Ampulla of vas deferens. 30 mins. x 15 
Fig. 74: 
Fig. 75: 
172 -
Prominent lysis by a thin-walled veino 
Adjacent artery is inactive. 30 mins. X 95 
Ampulla of vas deferens. Fibrin-digestion by 
the epithelium and subepithelial vessels. 60 mins. 
X 95 
Fig. 76: 
Fig. 77: 
17,3 -
Vas deferens. Epithelial activity. 30 mins. X 95 
Vas deferens. Fibrinolysis 
disrupted epithelial cells. 
arising from 
60 mins. X 95 
Fig. 78: 
Fig. 79: 
17i4 -
Activity from a detached clump of epithelial 
cells, and the adjacent vas epithelium. 60 mins. 
X 95 
Zones of digestion localized to smooth muscle 
in the wall of the vas. 60 mins. X 95 
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PLASMINOGEN ACTIVATOR IN THE SEMINAL VESICLE 
Fibrin-slide preparations were made from the seminal 
vesicles taken from 14 cases. As before, the fibrinolytic 
activity of the tissue components in 6 autographs from each 
case was assessed in arbitrary units, and the results are 
shown in Table 28. 
The blood vessels were consistently active, and the 
oiverticula were encircled by wide bands of fibrinolysis 
in the fibromuscular stroma (Figs. 80, 81 and 82). However 
the most interesting feature was the impressive epithelial 
activity seen in the sections. The epithelium of the 
diverticula, arranged in numerous tall ridges, recesses and 
anastomosing folds to form an alveolar surface, often 
exhibited striking fibrinolysis. Foci of activity arose 
from this honey-combed surface, punctuating the epithelial 
lining of the diverticula (Figs. 80, 82). 
Scattered within the lumen of each diverticulum, were 
many disrupted cells and fragments of cellular debris , and 
areas of fibrinolysis were often related to these (Figs. 83, 
84 and 85). Because of the dispersed cellular debris, it 
was difficult to find zones of digestion related only to 
the/ 
TABLE 28: 
Necropsy 
No. 
1 
2 
3 
5 
6 
7 
8 
9 
10 
1 1 
12 
13 
- 14 
15 
Average 
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Fibrinolytic Activity of Tissue Components of 
the Seminal Vesicles 
Overall Vascular Epithelium Secretions Activity 
12 12 12 0 
16 16 8 6 
16 16 8 8 
16 16 10 2 
16 16 10 2 
16 . 16 10 0 
16 16 16 8 
1 6 1 6 6 0 
16 16 10 4 
18 18 16 6 
16 16 16 8 
18 18 16 10 
16 16 16 2 
16 1 6 12 0 
16 16 12 4 
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the secretions, but at infrequent intervals, such foci 
were noticed (Fig. 80). Careful examination of the 
spermatozoa within the vesicular secretion revealed that 
these remained inactive (Fig. 86). 
Specimens of vesicular fluid were obtained at 6 
necropsies, and without overmuch delay, thick smears of 
the fluid from each case were made on 6 coverslips. Next, 
fibrinolysis autographs were made, incubating half of the 
preparations for 60 minutes at 37°c.; the remaining 
number were exposed at 4°c. for 24 hours, followed by 
incubation at 37°c. for 30 minutes. In every sample, 
well-marked digestion of fibrin was produced by the 
vesicular fluid (Fig. 87). However, no fibrinolysis was 
localized to spermatozoa in Jthe specimens (Fig. 88). 
It is possible that substances in the secretory 
material of the vesicle may inhibit the potency of plasmin-
ogen activator in the epithelial cells. To test this 
idea, seminal vesicles from 3 cases were slit open and 
their contents were thoroughly washed out in running tap 
water. Fibrinolysis autographs were constructed, and 
the fibrinolytic activity of the tissue compon~nts was 
assessed (Table 29). 
It/ 
TABLE 29: 
Necropsy 
No. 
1 
2 
3 
Average 
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Fibrinolytic Activity of Tissue Components of 
Washed Seminal Vesicles 
Overall Vascular Epithelium Secretions Activity 
10 10 2 0 
12 12 12 0 
16 16 12 0 
13 13 9 0 
It is seen that the overall activity was only mildly 
diminished, and that the general pattern remained identical 
to the activity in unwashed vesicles. Epithelial activity 
still remained as striking as before (Fig. 89), confirming 
that plasminogen activator is firmly bound to the intact 
cells, and showing that removal of the vesicular fluid, 
containing possible inhibitory factors, had not affected 
fibrinolysis by the epithelium. 
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Fig. 80: Diverticulum of the seminal vesicle, with zones 
of digestion related to blood vessels, glandular 
epithelium and secretion. 30 mins. X 24 
Fig. 81: Fibrinolysis occurring at the epithelial a1reolar 
surface. 30 mins. X 95 
Fig. 82: 
Fig. 8.3: 
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Lysis produced by stromal vessels, glandular 
epithelium, and desquamated epithelial cells • 
.30 mins. X 24 
Zones of digestion related to disintegrating 
cells. 60 mins. X 152 
l 8'2 -
Fig. 84: .30 mins. X 608 Seminal vesicle 
• 
Wide areas of fibrinolysis related to cellular debris. 
Fig. 85: 60 mins. X 152 Seminal vesicle 
Fig. 86: 
Fig. 87: 
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Inactive spermatozoa in the secretion within 
a diverticulum. 60 mins. X 950 
Fibrin-digestion by vesicular fluid. 60mins. X 24 
Fig. 88: 
Fig. 89: 
- .184 -
Inactive sperm3tozoa within the vesicular fluid. 
Overnight at 4 C. X 760 
Fibrinolytic activity arising from the epithelium 
and blood vessels of a washed seminal vesicle. 
60 mins. X 95 
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TOPOGRAPHY OF FIBRINOLYTIC ACTIVITY IN 
THE BULBO-URETHRAL GLAND 
The secretion of the bulbo-urethral (Cowper's) glands 
is an additional constituent of seminal fluid. More is 
known about the biochemistry of their secretions in animals, 
where the glands can be quite large, than in man. For 
instance, in the boar, their thick white secretion is rich 
in sialo-protein which contributes to the content of 
mucoprotein in the seminal plasma (Mann, 1964). An "egg-
yolk-coagulating" enzyme, secreted by Cowper's glands, has 
been found in goat semen (Roy, 1957), but this ferment is 
more likely to be a lipase, rather than a proteolytic enzyme. 
In man, the glands are small, are of the compound tubulo-
acinar (alveolar) type, and it is thought that the part 
they play is probably very subsidiary. 
Eight bulbo-urethral glands were carefully dissected 
out, quick-frozen, and subjected to fibrinolysis autography. 
The fibrinolytic activity of the tissue compon~nts was 
evaluated in 6 autographs from each case, and the results 
are given in Table JO. 
In comparison with the scores achieved by tissue 
components/ 
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TABLE 30: Fibrinolytic Activity of Tissue Com12onents in 
the Bulbo-urethral Glands 
Necropsy Overall Vascular Glands Ducts Secretion No. Activity 
5 18 18 16 16 16 
6 18 18 16 1 6 0 
7 18 18 16 16 14 
8 18 18 16 16 10 
1 1 18 18 14 6 0 
1 2 18 18 14 6 0 
13 18 18 12 12 7 
14 18 18 10 0 0 
Average 18 18 14 11 · 6 
components of the male accessory glands examined previously, 
the blood vessels, glandular and ductal epithelium, and 
secretions each respectively recorded the highest levels 
of fibrinolytic activity. Indeed, the early 15 minute 
preparations (see Fig. 90) developed activity almost as 
maximum as that in the autographs incubated for 60 minutes. 
Although the blood vessels showed the most striking 
and/ 
. 
,, 
. .· 
. 
,. 
·, 
! .. 
r, 
- 188 -
and consistent activity (Fig. 90), the fibrinolysis exhibited 
by the flattened epithelial cells lining the glandular acini 
was remarkable (Figs. 91 and 92). The ducts were equally 
active, especially the larger ducts (Figs. 93, 94 and 95). 
The long ducts corrununicating with the bulbar urethra, too, 
exhibited prominent fibrinolytic activity (Fig. 96). 
Haphazard zones of digestion arose within the 
secretions (Fig. 95), but infrequently, the score of 
activity attained was of considerable magnitude. Foci 
of fibrinolysis were often related to striated muscle 
fibres (Fig. 97), especially where damaged (Figs. 98, 99), 
and occasionally to the numerous nerve fibres seen in the 
sections (Fig. 99). 
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Fig. 90: Autograph of bulbo-urethral gland showing 
prominent zones of digestion after 15 mins. 
incubation. X 24 
Fig. 91: Cowperts gland - lysis related to several acini. 
60 mins. X 95 
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Fig. 92: Acini in the bulbo-urethral gland exhibiting 
fibrinolytic activity. 30 mins. X 95 
Fig. 93: Epithelial activity in a large duct, particularly 
where the cells are detached. 60 mins. X 24 
Fig. 94: 
Fig. 95: 
1 9 1 
Lysis related to the epithelial lining of a 
large duct in Cowperrs gland. 30 mins. X 24 
Activity from the epithelium and secretions of 
large ducts. 30 mins. x 24 
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Fig. 96: Bulbo-urethral gland - striking activity from 
the epithelium of a long excretory duct. 30 mins. 
, X 95 
Fig. 97: Fibrinolysis related to striated muscle fibres, 
particularly where damaged. 15 mins. x 95 
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Fig. 98: Area of lysis related to a small blood vessel 
situated in centre of photograph. Fibrinolysis 
by striated muscle fibres located on the right 
side of the autograph. JO mins. X 95 
Fig. 99: Lysis arising from nerve fibres situated on the 
left side of the autograph. Other foci from 
muscle fibres. 60 mins. X 95 
·.· 
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FIBRINOLYSIS BY ERECTILE TISSUE 
Blocks of tissue were taken from the bulb of the penis 
and corpus spongiosum in 12 cases, in order to obtain 
specimens of the penile or "spongy" urethra, and a series 
of fibrinolysis autographs from each case was constructed 
as before. Blocks of corpus cavernosum, too, were taken, 
so that further samples of erectile tissue could be 
studied. 
The endothelial lining of the large venous spaces 
or lacunae exhibited the most outstanding fibrinolysis yet 
seen in these studies, and excellent examples were often 
observed after only 15 minutes incubation (Figs. 100, 101 
and 102). Digestion was so extensive after 60 minutes 
of incubation, that the autographs were mostly unsuitable 
for the identification of microsco~ic detail. 
Remarkable zones of lysis were constantly related to 
detached endothelial cells (Figs. 103, 104). Although 
foci of activity were often related to the cells of the 
urethral mucosa, it was difficult to distinguish suitable 
areas for photography due to overlap by gross vascular 
activity. 
related/ 
Impressive areas of digestion were frequently 
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related to acini of the short and long urethral glands 
of Littr~ (Fig. 105). 
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15 mins. X 24 
Fibrinolysis arising from the endothelial-lined lacunae. 
Fig. 101: Corpus cavernosum. 
.30 mins. X 15 
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Fig. 102: Bulb of penis consistent endothelial 
activity. 15 mins. X 24 
•. 1( 
Fig. 103: Bulb of penis - striking digestion by detached 
endothelial cells. 15 mins. X 95 
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Fig. 104: Corpus cavernosum - lysis arising from endothe-
lium, particularly where disrupted. 15 mins X 95 
Fig. 105: Corpus spongiosum fibrinolysis related to 
acini of the urethral glands of Littre. 30 mins. 
X 95 
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FIBRINOLYTIC ACTIVITY IN THE MALE 
REPRODUCTIVE ORGANS 
Human seminal plasma ~s comprised of the secretions 
-produced by the male accessory organs, viz. epidydimides, 
vasa deferentia, ampullae of the vas, seminal vesicles, 
prostate, bulbo-urethral (Cowper's) glands, urethral 
(Littre's) glands and the preputial gland. The develop-
ment of the male accessory organs, their secretory capa-
city, and the highly specialized nature of their glandular 
secretions, is directly influenced by male sex hormone. 
After examining fluid obtained by prostatic massage, 
Huggins and his associates (1942, 1943) presumed that the 
source of seminal fibrinolysin was the prostate. A 
direct relationship was established between the number of 
leucocytes in prostatic secretion from patients with 
chronic prostatitis and the fluid's activity (Huggins and 
McDonald, 1944). Attempts have been made to correlate 
the size of the prostate (estimated by rectal examination) 
with the fibrinolytic activity of seminal fluid. 
Karhausen and Tagnon (1955) attributed the fibrinolytic 
activity of the prostate to a trypsin-like protease, and 
not/ 
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not to the presence of plasminogen activator. 
These previous findings were proved to be fallacious. 
Harvey (1949) showed that the fibrinolytic activity of 
seminal plasma was independent of the volume of prostatic 
fluid. Ying and others (1956) believed that only half of 
the fibrinolytic activity of semen could be ascribed to 
prostatic secretion. They suspected, too, that fluid 
obtained by prostatic massage would be contaminated by 
vesicular or urethral fluid. Furthermore, it is now 
known that the prostate is rich in plasminogen activator 
(Albrechtsen, 1957; Rasmussen, Albrechtsen and Astrup, 
1958; Rasmussen and Albrechtsen, 1960a). 
It has been demonstrated clearly and abundantly in 
these studies that the glandular epithelium of the 
accessory organs contains plasminogen activator in varying 
amounts, and it will be confirmed later that activator 
is responsible for the fibrinolytic activity of semen. 
Albrechtsen (1957) has shown the plasminogen activator 
content of testis to be low, viz. 25 tissue-activator 
- --
units; that of striated muscle was a little higher, viz. 
110 units; whilst the prostate, with 334 units, was one 
or I 
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of the richest tissues in activator concentration. It 
was interesting to note the presence of active striated 
• muscle fibres within the prostate. Although not recorded 
in standard histological descriptions of the prostate, 
striated muscle fibres have often been observed within 
the prostatic capsule (Kost and Evans, 1964). 
By means of a semi-quantitative method of fibrinolysis 
autography, it is shown in these studies that although 
vascular activity remains fairly constant (testicular 
vessels apart) in each of the male reproductive organs, 
the degree of epithelial fibrinolysis increases progressively 
down the genital tract (see Table .31). The concentration 
of plasminogen activator both in epithelium and secretion 
appears to be greatest in the bulbo-urethral gland, 
followed by the seminal vesicle, and next, the prostate. 
The observation that human testicular vessels were only 
moderately active, is similar to the findings by Tympanidis 
and Astrup (1968) that lysis was rarely related to the 
vessels of rabbit testis and epidydimis. On the other 
hand, the blood vessels of the rat testis and epidydimis 
were quite active. 
TABLE J 1: / 
- 204 -
TABLE 31: Distribution of Fibrinolytic Activity in the 
Male Genital Tract 
Tissue Overall Vascular Epithelium Secretion Activity 
Testis 13 13 1 0 
Head 16 16 6 0 
'Epidydimis 
Body 16 16 5 0 
Vas Duct 15 15 7 0 
Deferens Ampulla 14 14 7 0 
Seminal Vesicle 16 16 12 4 
Anterior 17 17 1 1 3 
Prostate Posterior 16 16 9 2 
Vera 16. 16 1 1 2 Montanum 
Bulbo-urethral 18 18 14 6 gland -
-
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The seminiferous tubules were almost totally inactive, 
and the foci seen were usually related to areas of trauma. 
The seminiferous epithelium is made up by the germinal 
spermatogenic cells and the supporting cells of Sertoli. 
Throughout the studies, no evidence of fibrinolytic 
activity was seen related to spermatozoa. Activator has 
been located to the microsome portion of cells (Tagnon and 
Petermann, 1949a), and as the cells of Sertoli contain 
inclusion granules and mitochondria, and part of their 
function is to nourish the spermatogenic cells, it is 
likely that these supporting cells are responsible for 
the zones of fibrinolysis. 
Slight amounts of activator were detected in the 
epithelium of the epidydimis and vas deferens. Observa-
tion of the epidydimal autographs reveal that there is 
often a sharp demarcation between overlapping activity 
from the interstitial stromal vessels and the inactive 
secretions within the epidydimal tubules. These observa-
tions raise a question about the concentration of fibrin-
olytic inhibitors in the epidydimis, and for that matter, 
about the presence of inhibitors in the testis and the 
remaining accessory glands. 
and/ 
Indeed, an organ-specific 
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and sex-specific proteinase inhibitor has been discovered 
in large quantities in the vesicles and semen of many 
mammals, including man (Vogel, Trautschold and Werle, 
1 968) • 
It has been stated before that the normal secretory 
processes in male accessory glands are accompanied by 
definite changes in epithelial structure, varying from 
desquamation to cell rupture (Mann, 1964). Analysis of 
the glandular fluid reveals not only the secretion from the 
intact cells, but also the contents of disintegrating 
cells. These results are amply confirmed by the results 
of the histochemical technique. Although foci of 
fibrinolysis occurred at random and inconstant intervals 
along the epithelial surface, yet wherever cells were 
detached or damaged, their fibrinolytic activity was 
enhanced. Numerous examples have been shown where 
disrupted or detached epithelial cells in prostatic 
imprints; prostat_ic excretory ducts; the ejaculatory 
ducts in the vera montanum; seminal vesical fluid and the 
bulbo-urethral ducts have produced well-marked zones of 
fibrinolysis. Areas of digestion frequently arose from 
intact or detached cells of the urethral mucosa. 
Only/ 
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Only the secretions of the bulbo-urethral gland, 
seminal vesicle and prostate displayed fibrinolytic 
activity, the greatest source being the bulbo-urethral 
gland, with the prostate evincing the least activity. It 
is obvious that fluid obtained by prostatic massage will 
contain quantities of prostatic, vesicular, bulbo-urethral 
and urethral gland secretions, and such fluid will have 
striking fibrinolytic activity, influenced by the trauma 
of massage. 
Studying the localisation of activator in the cornea 
and conjunctiva by means of fibrinolysis autography, 
Pandolfi and Astrup (1967) reported that injury to the 
epithelial cells caused the release of plasminogen activator, 
and the more damaged the cells were, the greater was the 
fibrinolytic response. The present studies confirm these 
previous observations that the degree of lysis is propor-
tionate to the severity of the injury. 
As in the blood stream-, where ti:1ere exists a fine 
balance between coagulation and fibrinolysis, so in the 
urinary tract, where identical systems exist, the fibrin-
olytic mechanism maintains the patency of the tube system 
by/ 
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by digesting fibrinous deposits (Astrup and Sterndorff, 
1952a; Ladehoff, 1960; Charlton, 1966)~ A further 
example of fibrin-deposition obstructing a narrow duct is 
the case described by Kussmaul (1879) in which Stensen's 
duct of the parotid was obstructed. 
In the male genital tract, thromboplastic and 
fibrinolytic activators are released into the fluid from 
intact secreting cells and disintegrating cells. The 
potential build-up of fibrinous deposits is prevented by 
the phenomenon of fibrinolysis, and the tube system remains 
patent. Where the fibrinolytic mechanism fails, I 
suggest that fibrinous deposits will collect, and in the 
case of the prostate, lead to the formation of corpora 
amylacea (see Chapter VI). 
No similar bodies have been observed in the other 
accessory glands, particularly the seminal vesicle, which 
should be liable to the formation of fibrinous bodies, 
when considering that it secretes a fibrinogen-like protein. 
Indeed, vesicular fluid is rich in protein, is viscous, and 
stasis is favoured by the intricately interlaced epithelial 
folds. However, it has a higher level of fibrinolytic 
activity than the prostate, which prevents coagulation. 
Formation/ 
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Formation of cheese-like lumps has been observed in the 
vesicles of guinea-pigs and rats (Hunteri 1786). The 
impressive activity of the bulbo-urethral glands, together 
with their relatively simple gland and duct system, would 
preclude the formation of fibrinous plugs. 
By studying autographs made with unheated . and heated 
bovine fibrin, the finding by Ying and others (1956) and 
Rasmussen and Albrechtsen (1960a), that no plasmin is 
present in the prostate has been confirmed. The latter 
workers also detected pro-activator in saline extracts of 
prostatic tissue, which they thought came from the blood 
in the prostate, and not the parenchyma. They found two 
types of activator, of which one was stable tissue 
activator, and the other was thermolabile at acid reaction 
and identical to activator found in the blood. No 
lysokinase or trypsin-inhibitors were discovered. 
In order to complete the story of the fibrinolytic 
mechanism in the secretory epithelium, further studies 
would be required to search for the presence of pro-
activators and lysokinases, and to evaluate the influence 
of fibrinolytic inhibitors. 
CHAPTER XV 
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LOCALIZATION OF ACTIVATOR IN SEMINAL FLUID 
It has been shown in the previous studies, that the 
source of activator in human seminal fluid is the epithelium 
of the male genital _tract, particularly that of the bulbo-
urethral glands, seminal vesicle and prostate, in that 
order of importance. It seemed relevant to the previous 
studies to confirm the presence of activator in seminal 
fluid and to determine whether spermatozoa contained 
fibrinolysin. 
Six specimens of seminal fluid were stored at 4°c. 
until they could be examined within 12 hours after 
ejaculation. Microscopic examination of the fluid 
determined the sperm density and ascertained that most of 
the spermatozoa became motile when the fluid had been 
gently warmed. A sample of fluid was taken from each 
specimen, centrifuged to separate the cells from the plasma, 
and both the deposit and the supernatant fluid were 
reserved. Microscopic examination confirmed that the 
samples of seminal plasma were cell-free. The spermatozoa 
were re-suspended in 5.0 ml. Ringer-lactate solution, and 
washed three times with the same volume of fluid. 
Small/ 
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Small drops of semen were placed on films of unheated 
and heat-treated bovine fibrin, and incubated at 37°c. for 
60 minutes. The fibrinolytic activity in duplicate auto-
graphs was assessed in arbitrary units, and the results 
are given in Table 32. Impressive zones of digestion were 
seen in the unheated fibrin (Fig. 106) and in the heated 
fibrin (Fig. 107), demonstrating that seminal fluid 
contains plasminogen activator and plasmin in large amounts. 
In the small number of cases examined, it is confirmed 
that the sperm density bears no relationship to the 
~ fibrinolytic activity of seminal fluid. It has already 
been demonstrated that the fibrinolytic activity (Harvey, 
1949; von Kaulla and Shettles, 1953) and the viscosity 
(Tjioe and Oentoeng, 1968) of semen is not related to the 
sperm count. 
Next, autographs were made using drops of seminal 
plasma, and the areas of fibrinolysis obtained were as 
large (Fig. 108) as those made by semen. Specimens of 
seminal fluid were obtained from two vasectomy cases. 
Microscopic examination of the fluid, consisting chiefly 
of prostatic, vesicular and bulbo-urethral gland secretions, 
·confirmed that these specimens were sperm-free. 
graphs/ 
Aut~ 
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Autographs made with such fluid revealed striking zones 
of lysis (Fig. 109). Huggins and Johnson (1933) have 
determined that the chemistry of semen was not appreciably 
altered by vasotomy, which eliminates testicular and 
epidydimal secretions. 
Wet smears of washed spermatozoa were made on cover-
slips and allowed to dry. Fibrinolysis autographs were 
0 constructed from these, exposed at 4 C. for 24 hours, and 
then incubated at 37°c. for 30 minutes. No f ibrinolytic 
activity was seen related to the spermatozoa (Figs. 110 
and 111), and one small clear zone in the fibrin was 
thought to be an artefact (Fig. 110). Flat epithelial 
cells occasionally exhibited fibrinolysis (Fig. 111). 
Specimens of cervical mucus were obtained from patients 
undergoing gynaecological procedures. Washed spermatozoa 
from two cases were resuspended in 5.0 ml. Ringer's solution, 
and each suspension was t _horoughly mixed with a sample of 
cervical mucus. The mixtures were incubated at 37°c. for 
30 minutes, and from these, a series of autographs were 
0 made, exposing the preparations at 4 C. for 20 hours, 
followed by incubation at 37°c. for 45 minutes. 
olysis / 
Fibrin-
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Fibrinolysis autographs were prepared from a sample of 
vaginal f\uid obtained from a patient attending for post-
coital examination. 
In both the spermatozoa treated with cervical mucus 
(Fig. 112) and those in postcoital fluid (Fig. 113), no 
evidence of fibrinolytic activity was seen. figs. 114 
and 115 show striking zones of fibrinolysis related to 
epithelial cells in the female genital fluids. Indeed, 
vaginal epithelial cells have been found to be rich in 
plasminogen activator (Astrup, Henrichsen, Tympanidis and 
King, 1967). 
Clermont, Glegg and Leblond (1955), and Hathaway and 
Hartree (1963) were able to damage or dissolve the acro-
somes by treating spermatozoa with a 0.0125 - 0.25N solution 
of sodium hydroxide, so . releasing complex biochemical 
compounds and enzymes. The acrosomes could also be 
damaged by sodium carbonate solutions, CTAB, or by shaking 
up spermatozoa with glass beads. When the sperms had 
been stained with Giemsa or P.A.S., such disruption was 
visible at microscopic examination. It may be that damage 
to the cell membrane or acrosome can release a lytic factor, 
the so-called "zona lysin". 
activator/ 
If this factor is a tissue 
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activator or a plasmin-like enzyme, its presence will be 
revealed by fibrinolysis autography. The following 
experiment was therefore conducted to test this idea. 
Washed spermatozoa were re-suspended in 10 ml. 
Ringer's solution. Several autographs were made from 
wet smears of the suspension, to act as controls, and these 
were exposed at 4°c. for 18 hours, followed by incubation 
at 37°c. for 45 minutes. The suspension was now divided 
into two halves. On the assumption that ice crystals 
would damage the cell membrane, one portion, in a plastic 
test-tube was subjected to repeated freezing and thawing 
by plunging the test-tube into dry ice-acetone mixture, 
and alternately, into warm water. Autographs incorporating 
the spermatozpa were exposed overnight at 4°c., followed 
by incubation at 37°c. The second portion was mixed with 
an equal volume of 0.125N sodium hydroxide solution, and 
~ - .incubated for 45 mi~utes at 37°c. A series of wet smears, 
taken from the suspension, was allowed to dry. Half of 
these were stained with Harris's haematoxylin, and the 
other half were stained with Giemsa, so that the effect 
of alkali on the spermatozoa could be observed. 
fibrinolysis autographs were made as before. 
Fig. 117 / 
A set of 
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Fig. 117 shows damaged spermatozoa following treatment 
with sodium hydroxide, and then stained with Giemsa. 
Spermatozoa treated by freezing and thawing (Fig. 116), 
or with sodium hydroxide (Fig. 118) showed no evidence 
of ribrinolysis. 
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TABLE .32: Fibrinolytic Activity of Seminal Fluid 
Case Sperm Density Activity Activity 
No. millions/mlo Unheated Fibrin Heated Fibrin 
1 52 6 6 
2 143 6 6 
3 136 6 6 
4 75 6 6 
5 14 6 6 
6 105 6 6 
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Fig. 106: Fibrinolysis of unheated bovine fibrin by 
semen. 60 mins. X 5 
Fig. 107: Digestion of heated bovine fibrin by semen. 
60 mins. X 5 
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Fig. 108: Digestion of fibrin by seminal plasma. 
60 mins. X 5 
Fig. 109: Fibrinolysis by seminal fluid from a vasectomy 
case. 60 mins. X 5 
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Fig. 110: Inactive washed spermatozoa. Artefact
0
near centre 
of autograph. Overnight expogure at 4 c. for 24 
hours, then incubation at 37 c. for 30 mins. X 608 
Fig. 111: Inactive washed spermatozoa. Digestion of fibrin 
by epithelial debris. X 608 
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Fig. 112: Spermatozoa remain inactive after treatment with 
cervical mucus. Overnight exposure X 950 
Fig. 11J: Inactive spermatozoa in vaginal fluid. X 950 
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Fig. 114: Active epithelial cells in cervical mucus. 
X 608 
Fig. 115: Fibrinolysis by vaginal epithelial cells. 
X .380 
Fig. 116: 
Fig. 117: 
22J -
Spermatozoa treated by freezing and thawbng 
remain inactive. Overnight exposure at 4 c. X 760 
Spermatozoa treated with sodium hydroxide, then 
stained with Giemsa. X 760 
• 
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Fig. 118: Fibrinolysis autograph of inactive spermatozoa, 
damaged after treatment with sodium hydroxide. 
Overnight exposure at 4°c. X 760 
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DISCUSSION 
It has been shown by von Kaulla and Shettles (1953, 
1954) that human semen contains powerful fibrinolytic 
proteases. By testing heated and unheated bovine fibrin 
plates with samples of seminal fluid, they concluded that 
the fluid contained plasminogen activator and plasmin, 
and they also detected the presence of pro-activator and 
fibrinolytic inhibitors. Dilution enhanced the fibrin-
olytic activity of seminal fluid, due to the dilution of 
enzyme inhibitors. Their findings were corroborated by 
Lundquist, Thorsteinsson, and Buus (1955) and Rasmussen, 
Albrechtsen and Astrup (1958). 
That fibrinolysin ~ secreted by epithelial cells 
lining the male reproductive tract has been shown by these 
studies, but there is as yet no unequivocal proof that 
the normal liquefying activity of human semen is in fact 
directly due to the concentration of fibrinolysin. 
Although a rough test of fibrinolytic capacity is that a 
given sample of semen should liquefy within 20 minutes or 
so after ejaculation, delay in liquefaction is by no means 
a cause of male infertility. · 
important/ 
Other enzymes, too, may be 
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important, since liquefaction of abnormal non-liquefying 
samples of human semen can be induced by adding alpha-
amylase to the clotted specimen (Bunge and Sherman, 1954). 
The content of protein soon after ejaculation undergoes 
rapid changes of a proteolytic nature, as manifested by a 
progressive decrease in the concentration of nondialyzable 
protein nitrogen, and a simultaneous increase of non-
protein nitrogen, free amino acids, and later, free ammonia 
(Mann, 1963). Pathological conditions of the male 
accessory glands especially in the prostate, can produce 
definite changes in the pattern and rate of proteolysis. 
Huggins and Neal (1942) have localized the fibrinolytic 
activity of semen to the seminal plasma, and not to the 
spermatozoa, since the fibrinolytic activity is not 
influenced by passing the fluid through a Seitz filter. 
Thorough washing is required to remove any coating of 
seminal plasma from spermatozoa. Centrifugation, dilution 
and washing may inflict an injury upon the sperm cell not 
apparent to ordinary microscopic examination, and result 
in the loss or leakage of proteins and enzymes into the 
surrounding medium (Mann, 1964). Such factors need to 
be taken into account when appraising the lack of fibrin-
olysis / 
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fibrinolysis by spermatozoa in these experiments. 
In complete contrast to the findings of the present 
studies, plasminogen activator has been found present in 
spermatozoa, by Tympanidis and Astrup (1968). Washed 
rat sperms were more active than sperms from testicular 
and epidydimal tissue. Although untreated rabbit sperm-
atozoa became fibrinolytic only after prolonged incubation, 
washed cells were quite activeo They believed that 
washing with saline removed inhibitors which were only 
loosely bound to plasminogen activator. 
However, the finding which captured the most profound 
attention was that vaginal smears from human volunteers, 
and also mated rats contained spermatozoa which exhibited 
significant ribrinolysis. It was suggested that the 
activity of vaginal spermatozoa may be related to 
capacitation, a process which spermatozoa undergo in the 
female genital tract prior to fertilisation. Nevertheless, 
the finding of plasminogen activator in human spermatozoa 
must be accepted with reserve, since no attempt was made 
in their experiments to exclude the possibility of contam-
ination of the spermatozoa by seminal plasma activator. 
No/ 
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No fibrinolytic mechanism has been demonstrated in 
spermatozoa in these studies, despite attempts to trigger 
off such a process in isolated spermatozoa by treating 
them with female genital fluids, or by damaging their cell 
membranes. If components of the fibrinolytic system are 
present in spermatozoa, other methods may be necessary to 
expose such factors. Plasminogen activator :mtgn~. be 
demonstrable in sperms if the cells are initially treated 
with activator-releasing agents, such as "Triton X 10011 , 
saponin, citric acid or endotoxin (Lack and Ali, 1964). 
Alternatively, the fibrinolytic component may be in pro-
activator form, and the sperm would need to be treated 
with a lysokinase, e.g. streptokinase, before fibrinolysis 
is evident. 
Spermatozoa change in nature during their ' passage 
through the genital tract. For instance, they acquire 
antigens from the accessory glands, mainly the prostate and 
seminal vesicles (Weil and Rodenburg, 1960). There is 
evidence that the process of sperm maturation is not halted 
at ejaculation, but continues in the female reproductive 
tract, where the sperms undergo a definite change called 
"capacitation" !Jefore becoming capable of penetrating the 
egg I 
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egg surface (Austin, 1951; Chang, 1951). 
Capacitation of the spermatozoa occurs during their 
traverse of the uterus and Fallopian tubes, and this 
~ process involves certain structural changes in the sperm-
head. The acrosome becomes elevated and detached from 
the sperm before it reaches the zona pellucida (Austin 
and Bishop, 1958), reminiscent of the "acrosome reaction" 
of the sperms of marine invertebrates. The modified 
acrosome is then said to release hyaluronidase which 
burrows a tunnel through the cumulus 6bphorus in advance 
of the penetrating sperm. 
Removal of the acrosome exposes the perforatorium, 
which is thought to carry zona lysin, probably a mucolytic 
enzyme. The zona lysin alters the zona pellucida, so 
that the sperm can get into the perivitelline space. 
Finally the sperm has to penetrate a final barrier, the 
surface of the vitellus. The sperm possibly carries an 
inhibitor which must be removed before the mucolytic enzyme 
can act on the zona. The inhibitor has been termed 
"dee apaci tating factor". Recent work at Cambridge has 
revealed that it can be removed by immersion of the sperm 
in I 
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in follicular fluid (Edwards, 1969). The enigma 
concerning penetration of the egg may be solved by 
capacitating sperms either by retaining them temporarily 
in the uterine cavity or Fallopian tube, or by treating 
them with follicular fluid, and then examining them by 
means of fibrinolysis autography. 
All genital fluids contain components of the fibrin-
olytic system, but their biological significance is not 
yet clear. The finding by Goldblatt (1935) that seminal 
fluid was rich in thromboplastic substances, has been 
confirmed by von Kaulla and Shettles (1956), who detected 
their presence, too, in cervical mucus, amniotic and 
follicular fluid. A globulin has been found in cervical 
mucus which inhibits trypsin (Schumacher and Pearl, 1968), 
and von Kaulla (1952) has observed that cervical mucus is 
free of antiplasmin at midcycle. The secretion of these 
inhibitors is influenced by sex hormones, and their function 
may be connected with sperm migration. 
The physiological significance of the fibrinolytic 
enzyme system in seminal plasma is not yet clearly under-
stood. Its main purpose may be to maintain the semen in 
a/ 
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a fluid state during its storage and passage through the 
genital tract (Mann, 1964). By dissolving the copulatory 
plug, it expedites sperm migration from the site of 
deposition until they make contact with the ovum. Motile 
spermatozoa may carry a coating of seminal fluid with them, 
which may influence the process of capacitation. The 
fibrinolytic activity of seminal fluid may facilitate both 
the entry of the sperm into the uterine cavity by 
dissolving cervical mucus, and their penetration of the 
zona pellucida. 
CHAPTER XVI 
SUMMARY OF THE THESIS 
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SUMMARY OF THE THESIS 
The cycle of coagulation and liquefaction of seminal 
fluid resembles the clotting and fibrinolysis of blood. 
Indeed, human semen contains a substance which can activate 
the blood fibrinolytic system; it has been assumed that 
this II activator" is of prostatic origin, and is an enzyme 
identical with the semen-liquefying protease. 
The histochemical technique of "fibrinolysis auto.... 
graphy" reveals the topography of plasminogen activator in 
tissues. Using a semi-quantitative method of the technique, 
tissues of the male genital tract were studied. Samples 
of tissues were taken from enucleated prostate glands at 
operation, and at necropsy from testis, epidydimis, vas 
deferens, seminal vesicle, prostate, bulbo-urethral gland, 
corpus spongiosum and corpus cavernosum. The regional 
distribution of fibrinolytic activity in the prostate was 
surveyed, and the effect of various factors on the sensit-
ivity of plasminogen activator was studied. Spermatozoa 
and samples of seminal fluid were likewise tested. 
Preparations from such samples confirmed that the 
greatest fibrinolytic activity arose from the blood vessels, 
except / 
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except in the testis, where their activity was less 
striking. Randomly distributed ~activity was localized 
to the epithelium in all parts of the male genital tract, 
except the testicular tubules, which were almost inactive. 
Epithelial activity was more impressive in the distal 
parts of the male genital tract, viz. bulbo-urethral gland, 
seminal vesicle and prostate, than in the proximal tissues. 
Fibrinolysis by epithelial cells was enhanced by 
desquamation and disruption. 
The development of prostatic corpora amylacea may be 
related to a disturbance in thea::i:uilibrium of coagulation-
fibrinolysis. Seminal plasma is rich in plasminogen 
activator. No fibrinolytic activity seems to be related 
to spermatozoa. 
The presence of activator maintains semen in a fluid 
state during its storage and passage through the genital 
tract. By liquefying the clot formed in ejaculated semen, 
activator facilitates sperm migration from the site of 
deposition, and it may play a role in the process of 
fertilisation. 
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